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ABSTRACT
Despite differing catalytic specificities and activities, farnesyl diphosphate 
synthase (FPPase) and chrysanthemyl diphosphate synthase (CPPase) from Artemisia 
tridentata ssp. spiciformis have sequence alignments showing 69% identity and 84% 
similarity. The active sites of the enzymes are formed by a six-membered, a-helical 
bundle representative of the type-I isoprenoid synthase fold (IS-1 fold). FPPase is 
selective for the 1’-4 coupling (chain elongation) of dimethylallyl diphosphate (DMAPP) 
and two isopentenyl diphosphate (IPP) molecules, initially forming geranyl diphosphate 
(GPP) and then farnesyl diphosphate (FPP). CPPase preferentially forms GPP when chain 
elongating, and can also couple two DMAPP molecules (irregular coupling) to 
preferentially form the c1’-1-2 product chysanthemyl diphosphate (CPP). CPPase 
additionally produces the 1’-2 product lavandulyl diphosphate (LPP) and a trace amount 
of the c1’-2-3-2’ product maconelliyl diphosphate (MPP). The catalytic diversity of 
CPPase comes at the cost of catalytic efficiency (kcat/Km), as FPPase chain elongates at 
over 30,000-fold greater efficiency. In this study chimeric enzyme constructs were built 
from the IS-1 folds of FPPase and CPPase. Each enzyme was turned into the other 
through sequentially swapping the helices and loops of their IS-1 fold, building enzymes 
of varying FPPase and CPPase character to assess what structural elements affect 
catalytic specificity and activity. The first catalytic transformation observed along the N- 
to C-terminal conversion of FPPase to CPPase was a shift from preferential FPP to GPP
formation. The GPPase showed over 2000-fold greater catalytic efficiency toward 
terminating chain elongation at the C10 product. Then, catalytic efficiency dropped to 
CPPase-like levels, correlating with a T194G FPPase to CPPase mutation of the KT motif 
in the fourth conserved region among E-chain elongation enzymes. Following, irregular 
terpenoid catalysis was observed in the form of preferential LPP formation, associated 
with F231Y and D235N mutations in the fifth conserved region. Preferential CPP 
production was dependent upon an enzyme having C-terminal sequence outside the IS-1 
fold from CPPase. Replacement of the N-terminal region outside of the IS-1 fold of 
CPPase with FPPase sequence reclaimed GPP binding ability and FPP formation. A 
return to an FPPase-like catalytic efficiency was not observed in any chimera along the 
N- to C-terminal metamorphosis of CPPase to FPPase, further indicating the significance 
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1.1 Charles Darwin and Alfred Wallace Had It Right 
In 1869 the great naturalist and author John Muir penned “when we try to pick 
out anything by itself, we find it hitched to everything else in the Universe” in his 
journal.1 Perhaps more truth and application lies in the thought than he realized. Earth 
touts an abundance of life, displaying it in bountiful forms and functions. Despite the 
apparently autonomous differences, the similarities arguably hold more significance -  life 
utilizes the same heredity material and genetic code, with proteins built using that code 
and common amino acids. It is through the synonymy that nature exists. No matter how 
unique the appearance and functionality a creature appears, it finds itself hitched to all 
other life through fundamental biochemical processes.
In 1858 the idea of the evolution of species from a common ancestor at the hand 
of natural selection was copresented by Charles Darwin and Alfred Wallace. The action 
coined by Darwin as natural selection is, in short, the nature of organic beings to 
“multiply, vary, let the strongest live and the weakest die.”2 The rationale behind the 
selective action is that favorable variations are preserved in future generations due to an 
advantage in environmental utilization and proliferation. Natural selection was a hard sell 
for many scientists and struggled to find acceptance. It was not until the discovery of
genes and mutations in the 20th century that natural selection was not only alluring as an 
explanatory tool, but also required. We now know natural selection as part of divergent 
evolution, which produces new biological traits and nature’s diversity through the 
duplication and modification, and domain swapping of genes.3,4
1.2 A Comment on the Interconnectivity of the Domains of Life
The affinities of all the beings of the same class have sometimes been represented 
by a great tree. As buds give rise by growth to fresh buds, and these if vigorous, branch 
out and overtop on all sides many a feebler branch, so by generation I believe it has been 
with the great Tree of Life, which fills with its dead and broken branches the crust of the 
earth, and covers the surface with its ever branching and beautiful ramifications.
Charles Darwin, On the Origin of Species, 1859
The earliest known life existed on Earth more than 3.7 billion years ago.5 In that 
time a vast range of relatively simple to complex organisms evolved and inhabit this 
domain from one “unearthly” extreme to another. A phylogenetic tree is used to 
characterize the evolutionary relationships among life’s creatures, with each branch point 
representing where divergence from a common ancestor occurred and closely related, yet 
distinct organisms continued on unique paths. Life is categorized into one of three 
Domains -  Archaea, Bacteria, and Eukaryota (Figure 1.1).6 The fundamental difference 
among organisms is the presence or lack of membrane-bound organelles. Archaea and 
Bacteria lack organelle membranes and are termed prokaryotic, whereas eukaryotic 
organisms have, at minimum, their genetic material encapsulated in a membrane structure 
we know as the nucleus.
The Archaea and Bacteria domains consist of microorganisms typically a few 
micrometers in length and varying in shape. Archaebacteria are commonly thought of as 
extremophiles, living in hot, salty, or acidic environments too inhospitable for most
2
3Figure 1.1. A highly resolved Tree of Life, derived from completely sequenced genomes, 
distinguishing between the three domains of life. Eukaryotes are colored red, bacteria
blue, and archaea green.7
beings, yet are found in a wide range of habitats, including the human navel. 
Extremophilic archaea, especially those resistant to heat or pH extremes, are a source of 
enzymes capable of tolerating the harsh conditions, for example, the revolutionizing 
thermostable DNA polymerases used for quick and easy DNA cloning. Akin to their 
archaeal counterparts, bacteria are found in nearly every corner of the earth. In fact, there 
are roughly 40 million bacterial cells in a gram of soil, and one million in a milliliter of 
water.9 Surprisingly, the biomass of bacteria on Earth outweighs that of plants and 
animals combined.10 The versatility of bacteria are harnessed in a variety of industrial 
processes such as cheese and yogurt production, sewage treatment, and antibiotic 
production. The adaptability of bacteria is unmatched, and therefore their ability to thrive
in a multitude of environments.
Although there are numerous unicellular eukaryotic organisms, such as the 
protozoa, we tend to be more aware of our multicellular eukaryotic counterparts -  mainly 
those from the kingdoms Plantae, Animalia, and Fungi. This awareness is not without 
good reason, a rich evolutionary history exists among these kingdoms. Long have 
animals relied on other animals, plants, and fungi for sustenance, and vice versa. In that, 
it is sometimes easy to lose perspective of the entire picture, there is much more than 
meets the eye. For example, humans have ten times more microbial cells than their own, 
and that microbiome affects our physical and psychological well-being.11-13 Humans may 
be more aptly described as superorganisms whose metabolism is a combination of 
microbial and human facets, in fact, it appears most organisms are just one part of an 
interdependent metaorganism.14,15 Since the beginning of life some 3.7 billion years ago 
organisms have evolved and diversified together, formed symbioses and battled 
competitively. Over the years, interactions of give and take have molded the species into 
what lives and exists today, each with a uniqueness celebrating the long evolutionary 
struggle to multiply, diversify, and thrive in ever-changing environmental niches.
1.3 The Exceptional Biosynthesis of Secondary Metabolites by Plants 
Plants are specialized in their ability to photosynthesize through harvesting light 
energy, carbon dioxide, and water to build chemical energy in the form of sugar, and in 
doing so release oxygen. Through the maintenance of atmospheric oxygen levels and 
supply of energetic organic compounds, photosynthesis is arguably the most important 
process to supporting life on Earth.16 Plants exhibit an exceptional ability to synthesize
4
5structurally and chemically diverse low molecular weight compounds, numbering into the 
hundreds of thousands.17 Few of the compounds are deemed as “primary” metabolites, 
which are those produced ubiquitously by all plant species and other organisms (sugars, 
amino acids, nucleotides, lipids, and energy sources).18 The remaining “secondary” 
metabolites are described as compounds not directly involved in the growth, 
development, or reproduction of an organisms.
It is generally agreed that phytochemistry began when Friedrich Wilhelm 
Serturner isolated morphine from Papaver somniferum (commonly known as the Opium 
poppy) over 200 years ago (Figure 1.2).17 The attribution of the active component in a 
plant drug to a single chemical compound began natural (secondary) product chemistry. 
One active secondary metabolite isolate after another was identified, and swift progress 
in natural product research fueled growth in synthetic, analytical, and pharmaceutical 
chemistry. The synthesis of indigo, a plant secondary metabolite, by Adolf Baeyer and 
Viggo Drewson in 1882 marks a milestone in synthetic organic chemistry. In 
continuation with the classic opioid, Robert Robinson elucidated morphine’s structural 
formula in the 1920s, with the total synthesis completed by Marshall Gates in 1956.19 The 
ability to map plant biosynthetic pathways using radiolabeled tracer techniques began in 
the mid-20th century with the introduction of 14C and 3H labeled compounds, and in the 
following decades the pathways for many of the significant secondary metabolite classes 
were defined.17
Secondary metabolites were selected over the course of evolution to address 
specific needs, many due to the sessile nature of plants. The colors and scents of flowers 
are evolved to attract insect pollinators to increase the chance of fertilization.20,21 Toxic
6Figure 1.2. Structure of morphine.
chemicals provide defense from pathogens and herbivores, or may inhibit the growth of 
neighboring plants.22-25 Chemicals in fruit provide delightful scents, colors, and flavors to 
promote animal consumption and seed dispersal. Furthermore, humankind has utilized 
natural products for thousands of years for a wide range of purposes including flavors, 
fragrances, dyes, stimulants, insecticides, hallucinogens, poisons, and therapeutics.18
The chemical solutions to common obstacles vary among plant lineages.4 The 
scents of flowers greatly differ from species to species, and although the compounds 
synthesized to deter herbivores are vast, individual lineages only produce a small portion 
of them.26,27 Plant genomes contain an estimated 20,000 -  60,000 genes, with 15-25% of 
those genes encoding enzymes for secondary metabolism.4
Natural products can be divided into three main classes -  phenolic compounds, 
terpenoids/isoprenoids, and nitrogen or sulfur containing compounds (such as alkaloids 
and glucosinolates).18 As expected from an evolutionary standpoint, the three main 
classes of secondary metabolites are biosynthetically linked to primary metabolic 
pathways (Figure 1.3). Genes for secondary metabolites may evolve from already 
existing natural product genes, or genes for primary metabolites; nonetheless, it is likely 
the ancestor gene was associated with primary metabolism, which serves as a pool for
7Figure 1.3. The biosynthesis of plant secondary metabolites is closely linked to primary
metabolic pathways. 18
new secondary metabolite-related genes. ,4,18
1.4 The E-Terpenoid Biosynthetic Pathway 
The isoprenoid biosynthetic pathway is one of nature’s largest and most diverse. 
With over 62,000 natural products, terpenes include many well-known groups including 
sterols, ubiquinones, carotenoids, and essential oils.28-30 Despite responsibility for a wide 
structural array of chemicals, isoprenoids are simply built from coupling 3-methyl-1- 
butyl (isoprene) units. Dimethylallyl diphosphate (DMAPP) and isopentenyl diphosphate 
(IPP) are the universal isoprene units coupled to make terpenoid skeletal backbones in 
one of four ways -  chain elongation, branching, cyclopropanation, and cyclobutanation.29
8Chain elongation is considered a regular or head-to-tail coupling, while the others are 
irregular or nonhead-to-tail (Figure 1.4). Chain elongation is by far the most common 
coupling reaction, showing ubiquity across organisms. Two families of regular chain 
elongation enzymes exist and are grouped based upon the stereochemistry of the double 
bond in the added isoprene unit -  E  or Z. Generally, E-polyprenyl diphosphate synthases 
produce short-chain products early in the biosynthetic pathway, whereas Z-family 
enzymes make longer-chain products, notably the 105-106 Dalton compound natural 
rubber.31
If the E -terpenoid pathway is viewed as a tree, the mevalonate (MEV) and non- 
mevalonate (or methylerythritol/deoxyxylulose phosphate, MEP/DXP) pathways are the 
roots (Figure 1.5). These independent, nonhomologous pathways produce nature’s source 
of DMAPP and IPP. Most eukaryotes, archaea, and some eubacteria utilize the MEV 
pathway.32 Three acetyl-Coenzyme A molecules are condensed and converted into IPP, 
from which the enzyme isopentenyl diphosphate isomerase (IDI) generates DMAPP. The 
MEV pathway is highly relevant to human health -  inhibiting 3-hydroxy-3-methyl- 
glutaryl-CoA (HMG-CoA) reductase by statins limits sterol production, thereby lowering 
cholesterol and blood pressure, among other potential health benefits.33 Until relatively 
recently, the MEV pathway was thought of as the straightforward, sole source of the 
foundational isoprene units, but continued discoveries indicate the MEV pathway is more 
complex than originally thought.34-36 The MEP pathway appears in cyanobacteria, algae, 
eubacteria, plant chloroplasts, and apicomplexan parasites.32 Pyruvate and 
glyceraldehyde-3-phosphate are condensed and converted into the terpenoid building 
blocks. The MEP pathway does not require IDI as DMAPP and IPP are both produced
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Figure 1.4. Isoprenoids are built from four fundamental coupling reactions -  chain 
elongation, branching, cyclopropanation, and cyclobutanation.
from the final substrate via (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMB- 
PP) reductase.
The trunk of the pathway, which symbolizes chain elongation, extends from the 
tree’s roots. In the E-chain elongation pathway, the first coupling sequence linearly links 
DMAPP and IPP (1’-4, respectively) to produce the monoterpene (C10) geranyl 
diphosphate (GPP). The prenyl transfer reaction occurs through a dissociative 
electrophilic alkylation, finalized by extraction of the pro-R proton at C2 of the IPP unit 
to produce the E  stereochemistry (Figure 1.6).37,38 GPP can linearly couple with another 
IPP molecule and extend to the sesquiterpene (C15) farnesyl diphosphate (FPP), and so on 
up the trunk. This ability to sequentially extend the chain with IPP is central to the 
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Figure 1.6. The chain elongation reaction occurs through a dissociative electrophilic
alkylation.
prenylation of proteins by FPP or GGPP for protein-membrane anchoring and cell signal 
transduction, each chain elongation product is a branching point in the biological 
pathway.39 A linear isoprenoid can cyclize or irregularly couple with itself to produce an 
array of structures that may undergo further modification and specification, branching out 
from the tree’s trunk and creating an isopenoid subclass, such as the sterols, carotenoids 
or gibberellins (branching from FPP or GGPP, respectively) (Figure 1.7).
Nature exhibits several isoprenoid backbone structures outside of the four 
fundamental couplings (Figure 1.8). Some are found in limited cases, the 4’-4 (tail-to- 
tail) coupling is present in archaeal cell membranes composed of the diterpene phytane 
and the 1’-2 (branched) coupling is exhibited in select plants.40-42 Also, the c1’-2-3-2’ and 
c2’-2-3-4-3’ connectivities (cyclobutyl and cyclopentyl) show near exclusive production 
as mealybug pheromones.43-45 Most irregular couplings traverse through a c1’-2-3 
(cyclopropyl) intermediate via a dissociative electrophilic alkylation mechanism. The 
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Figure 1.7. Overview of the E-chain elongation pathway used for the biosynthesis of 
terpenoids (DXP, deoxyxylulose; MEV, mevalonate; IDI, isopentenyl diphosphate
isomerase).
biosynthesis of the 1’-1 linked squalene initiated great thought on the biogenesis of non- 
head-to-tail couplings.46,47 Soon after, it was discovered that the cyclopropyl-coupled 
prephytoene, a C40 analogue of presqualene, was the intermediate between 
geranylgeranyl diphosphate and the 1’-1 coupled product phytoene; and it was 
recognized and demonstrated that c1’-2-3 cationic rearrangements led to the formation of 
1’-3, 2-1’-3, and c1’-1-2 couplings.48-50 Then strong evidence for a cyclopropyl 








Figure 1.8. Isoprenoid coupling patterns observed in nature. The four fundamental 
couplings are enclosed in dashed lines.
obtained through stable-isotope labeling experiments.51,52 Eventually a chrysanthemyl 
diphosphate synthase was isolated that demonstrated the ability to produce all four 
fundamental coupled products, and does so through the cyclopropyl intermediate (Figure 
1.9).29 Finally, botryococcene-like compounds reported from organic-rich lakebed 
sediments and plant extracts with a peculiar cyclopentane coupling (C1’-3-4-5-6) was 
recently identified as a promiscuous product from a recombinant squalene synthase. 53-55 
One could argue that chain elongation and cyclopropanation are the sole 
fundamental couplings. Chain elongation is undoubtedly a fundamental coupling due to 
its uniqueness and pivotal role in the isoprenoid pathway, and cyclopropanation due to its 
formation and rearrangement as a prerequisite for most other couplings. Regardless, the 
complexity and diversity of products originating from the union of relatively simple five 
carbon units is not only impressive, but also utilized by all forms of life except a small
14
Figure 1.9. The fundamental, irregularly coupled products of the isoprenoid biosynthetic 
pathway utilize a common mechanism that initially traverses through a cyclopropyl, 
carbocationinc intermediate (DMAPP, dimethyallyl diphosphate; CPP, chrysanthemyl 
diphosphate; LPP, lavandulyl diphosphate; MPP, maconelliyl diphosphate; PPP,
planococcyl diphosphate).
group of parasitic bacteria.57 Nature’s development and evolution of the terpenoid 
biosynthetic pathway provides a marvelous and rich source of industrially and 
pharmacologically relevant secondary metabolites, in addition to a seemingly endless 
base for scientific research.
1.5 The Type-I Isoprenoid Synthase Fold: Sage Farnesyl and 
Chrysanthemyl Diphosphate Synthases 
The type I isoprenoid synthase (IS-1) fold is intimately involved in the E-chain 
elongation pathway. The all a-helical bundle and connective loops of the IS-1 fold were 
first observed in the x-ray structure of avian farnesyl diphosphate synthase (FPPase)
(Figure 1.10).58 Since its debut in FPPase, the a-helical fold has been observed in other 
E-polyprenyl diphosphate synthases, enzymes catalyzing nonhead-to-tail reactions, and 
terpenoid cyclases, making enzymes exhibiting the structure members of a
29 59 62superfamily. , ' Currently over 16,000 IS-1 fold sequences reside in databases and the 
number continues to increase.63 IS-1 enzymes utilize DDxxD/E (“aspartate rich”) amino 
acid motifs to coordinate Mg2+ ions in a trinuclear complex that binds substrate 
diphosphates and catalyzes ionization.62,64,65 Pyrophosphate departure triggers formation 
of carbocations, which the enzymes elegantly stabilize, protect while chaperoning 
rearrangement, and subsequently quench to finalize product formation.
The prevalence of the IS-1 fold suggests divergent evolution from a common primordial 
ancestor early in the evolution of terpene biosynthesis. Enzymes with such structural 
homology catalyzing subsequent steps in a biosynthetic pathway likely share an 
evolutionary origin.66 Strong support for the idea was obtained with the isolation of 
closely related farnesyl and chrysanthemyl diphosphate synthases (FPPase and CPPase, 
respectively) from snowfield sagebrush Artemisia tridentata ssp. spiciformis, both 
enzymes being IS-1 fold homodimers.67 FPPase is specific for the production of the 
regularly coupled C15 compound farnesyl diphosphate, whereas CPPase is catalytically 
promiscuous and exhibits all the fundamental couplings in its products (Figure 1.11). 
Despite an apparent catalytic gap between the enzymes, their sequence alignments show 
a striking 69% identity and 84% similarity, not only implying a recent divergence of the 
genes from a common origin, but also perhaps the evolution of cyclopropanation activity 
from an ancestral E-chain elongation enzyme (Figure 1.12).56
It is not surprising snowfield sagebrush evolved an enzyme with the synthetic
15
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Figure 1.10. Monomeric crystal structure of sagebrush FPPase. Helices and loops of the
IS-1 fold are colored in red.
capacity of CPPase, since closely related members of the plant group boast the greatest 
variety of nonhead-to-tail terpenes.52 The distinguishing factor between the sagebrush 
enzymes is the ability of FPPase to exclusively bind IPP in the electron donor site for the 
prenyltransfer reaction. The E-polyprenyl chain elongases exhibit five conserved amino 
acid regions, and CPPase differs from FPPase by only two amino acids among the 
residues identified as important for substrate binding and activity in FPPase.67,68 The 
staggering sequence (and therefore structural) resemblance, yet contrasting catalytic 
activities between the sagebrush enzymes yields a unique opportunity to probe structure- 
function aspects of the IS-1 fold.
1.6 The Exploration of Structure-Function Relationships of the IS-1 Fold 
Through A. tridentata FPPase and CPPase Chimeras 
The use of chimeric proteins has proven utility in the enzymologist’s toolbox. 






















Figure 1.11. Reactions catalyzed by sagebrush FPPase and CPPase (IPP, isopentenyl 
diphosphate; DMAPP, dimethyallyl diphosphate; GPP, geranyl diphosphate; FPP, 
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Figure 1.12. Sage FPPase and CPPase amino acid sequence alignments illustrating the 
helices forming the structure of the enzymes, specifically the six helices of the IS-1 fold.
FPPase and CPPase amino acid sequence alignments show 69% identity and 84% 
similarity. Identical residues are in red, similar in blue, and different in black. The five 
conserved regions of E-prenyl chain elongation enzymes are highlighted in gray.
residues contributing to a desired function, and produce proteins for metabolic 
engineering.69-71 In the case of FPPase and CPPase chimeragenesis, the tool is used to 
mimic evolution using DNA sequences that underwent the scrutiny of natural selection.
The first set of chimeras constructed from the sagebrush enzymes was based on 
substitutions of the five conserved E-polyprenyl chain elongation regions. Restriction 
sites flanking the five conserved regions were engineered into the sagebrush genes and 
chimeric proteins made via “cutting and pasting” the desired DNA sequence segments -  
FPPase was turned into CPPase piece by piece.29 In parallel with the changes in sequence, 
the chimeras showed a transition in their product ratios. As FPPase transitioned into
CPPase, GPP became the primary chain elongation product over FPP, and irregular
19
activity went from none, to cyclobutanation/branching, to solely branching, to 
branching/cyclopropanation.55 Essentially, it appears the templates favoring catalysis of 
one fundamental coupling over another lie in the sequences of FPPase and CPPase.
The work presented in this dissertation is a continuation of sagebrush 
FPPase/CPPase chimeragenesis. This set of chimeras attempts to further deduce the 
structural elements in the IS-1 fold responsible for catalytic selectivity and activity. 
Instead of the five conserved E-chain elongation conserved regions, the chimeras were 
built around the a-helices and loops of the IS-1 fold. Chimeras were also assembled in 
both directions (turning FPPase into CPPase, and vice-versa) and done so using the 
polymerase chain reaction (PCR) in order to produce constructs that maintain wild-type 
enzymatic sequences. Product ratio and kinetic analyses were performed, if possible, in 
addition to molecular modeling of the parental enzymes and select chimeric enzyme 
constructs.
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2.1 Chimeragenesis Design 
The FPPase and CPPase chimeric enzyme constructs were built using the N- 
terminal sequence of one enzyme up to one of the 13 crossover points, at which the 
sequence from the other enzyme was used to finalize the gene. The polymerase chain 
reaction (PCR) protocol developed for chimeragenesis directionally cloned the chimeric 
genes into the pET15b vector (Novagen), linking an amino-terminal hexa-histidine tag to 
the expressed proteins to facilitate purification by Ni2+ Sepharose column 
chromatography. Naming of the chimeras was based upon the enzyme from which the N- 
terminal sequence was derived, F or C for FPPase and CPPase, respectively, and 
crossover point at which the sequence changes to the other enzyme. For instance, the 
“C6” chimera consists of CPPase sequence from the N-terminus to the sixth crossover 
point, with the remaining sequence from FPPase.
The beginning and ends of each IS-1 fold helix marks a crossover point, with an 
additional point between K193 and T194G (crossover 10) to separate the helical kinked 
pair of helix V. The locations of the IS-1 helices were identified from an apo sagebrush 
FPPase crystal structure (unpublished). The set of crossover points used in this work 
isolate the N- and C- terminal regions, and helices and loops of the IS-1 fold, building
enzymes of varying FPPase- and CPPase-like character using homologous regions. Each 
chimera provides insight into how a specific structural region defines the catalytic 
specificities and activities of the proteins (Figure 2.1). To fully assess the influence of the 
enzymatic structure outside of IS-1 fold, two additional “core-scaffold” chimeras were 
built. The additional proteins consist of the IS-1 fold region from one enzyme (core) with 
the N- and C-terminal regions of the other (scaffold).
2.2 Enzymatic Product Ratio Analyses
2.2.1 Enzymatic Products Formed Under Chain Elongation Reaction
Conditions
Enzymatic products formed under chain elongation reaction conditions were 
determined by incubating the enzymes with 500 ^M DMAPP and IPP at 30 °C for 2 h 
(Figure 2.2, Table 2.1). The diphosphate compounds were hydrolyzed to their alcohol 
counterparts through the action of calf-intestinal phosphatase (CIP), and then extracted 
using methyl tert-butyl ether (MTBE) for structural analysis by GC-MS.
As the N- to C-terminal transformation of FPPase into CPPase progressed, 
preferential FPP formation (> 78%) was maintained up through chimera C5. At the C6 
chimera, production of the C10 and C15 chain elongation products GPP and FPP, 
respectively, was evenly split. The shift to preferential GPP formation began at the C7 
chimera (61% GPP), with GPPase activity peaking at the C9 chimera (~ 95% GPP). GPP 
sustained as the major chain elongation product through the remaining FPPase to CPPase 
metamorphosis (Figure 2.3).
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Figure 2.1. Sequential and structural representation of the parental sagebrush enzymes 
highlighting the crossover points for chimeragenesis A. Sage FPPase and CPPase amino 
acid sequence alignment highlighting the helices and loops of the N-terminal (light gray), 
IS-1 fold (colored), and C-terminal (gray) regions. The 13 crossover points used for 
chimeragenesis are located at the beginning and end of each IS-1 fold helix. B. 
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Figure 2.2. Substrates used and products formed by FPPase, CPPase, and the chimeric
enzyme constructs.
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Table 2.1. Relative percentages of products formed by the FPPase, CPPase, C1-C13, F1- 
F13, c_F_c, and f_C_f enzymes under chain elongation incubation conditions (GPP, 
geranyl diphosphate; FPP, farnesyl diphosphate; CPP, chrysanthemyl diphosphate; LPP,
lavandulyl diphosphate).
GPP FPP CPP LPP
FPPase 8 ± 1 90 ± 1 - -
C1 9 ± 2 91 ± 2 - -
C2 21 ± 1 79 ± 1 - -
C3 6.8 ± 0.7 93.2 ± 0.7 - -
C4 15.9 ± 0.7 84.1 ± 0.7 - -
C5 22 ± 3 78 ± 3 - -
C6 52 ± 6 48 ± 6 - -
C7 61 ± 2 39 ± 2 - -
C8 67 ± 2 32 ± 2 - -
C9 94.5 ± 0.3 3.1 ± 0.2 - -
C10 78 ± 2 21 ± 2 - -
C11 72 ± 4 27 ± 4 - -
C12 88.4 ± 0.9 10 ± 1 - -
C13 64 ± 1 23 ± 1 2.7 ± 0.2 7.5 ± 0.2
CPPase 49 ± 1 2.0 ± 0.1 34 ± 1 11.4 ± 0.1
F1 64.9 ± 0.7 4.3 ± 0.9 17 ± 1 10.2 ± 0.6
F2 93.3 ± 0.6 4.4 ± 0.6 - -
F3 81 ± 6 19 ± 6 - -
F4 76 ± 2 24 ± 2 - -
F5 67 ± 2 33 ± 2 - -
F6 72 ± 3 28 ± 3 - -
F7 57 ± 8 43 ± 8 - -
F8 14 ± 2 83 ± 2 - -
F9 8 ± 2 90 ± 2 - -
F10 25.6 ± 0.8 71.9 ± 0.5 - -
F11 38 ± 4 60 ± 4 - -
F12 53 ± 3 46 ± 4 - -
F13 21 ± 5 77 ± 5 - -
c F c 11 ± 3 86 ± 3 - -





























Figure 2.3. Preferential formation of FPP shifts to preferential formation of GPP along 
the N- to C-terminal FPPase to CPPase metamorphosis (GPP, geranyl diphosphate; FPP,
farnesyl diphosphate).
Structurally, the chimera was almost entirely built from CPPase sequence, only the C- 
terminal region outside the IS-1 fold, was sequence from FPPase. The C13 chimera 
exhibited irregularly coupled products (~ 10%) under chain elongation incubation 
conditions, similar to CPPase (~ 45% irregular products), yet in contrast to CPPase, 
chimera C 13 preferentially formed the branched product LPP over the cyclopropyl CPP 
(Figure 2.4).
The first step of the N- to C-terminal, CPPase to FPPase transformation is the FI 
chimera, which is the CPPase enzyme with N-terminal sequence from FPPase. The FI 
chimera also competitively catalyzed irregular and regular couplings under incubation 
with DMAPP and IPP. The FI chimera preferentially catalyzes chain elongation to GPP, 
but similarly to CPPase, formed CPP as the major irregular product (65% GPP, 17%
CPP, 10%) LPP). Competitive irregular coupling ability was lost in the CPPase to FPPase
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CPP LPP GPP FPP
Figure 2.4. CPPase, chimera C13, and chimera FI competitively form regularly and 
irregularly coupled products under regular coupling conditions (CPP, chrysanthemyl 
diphosphate; LPP, lavandulyl diphosphate; GPP, geranyl diphosphate; FPP, farnesyl
diphosphate).
metamorphosis at the F2 chimera (93.3% GPP). In continuation along the 
metamorphosis, the formation of FPP was steadily reclaimed, reaching a maximum at the 
F9 chimera (90% FPP). Interestingly, FPP production then decreased at the F 10 chimera 
(~ 72% FPP), and continued to decrease through the F 12 chimera, where GPP and FPP 
production nearly equalized. The trend reversed once again, and FPP production was 
reclaimed at the F13 chimera (77% FPP) (Figure 2.5).
The chain elongation product ratios for the FPPase core-CPPase scaffold (c_F_c) 
chimera were comparable to parental FPPase (86% FPP). The CPPase core-FPPase 
scaffold (f_C_f) chimera resembled chimera C l3, showing preferential chain elongation 
to GPP (70%), with LPP formed almost exclusively over CPP (25% and 0.5%, 
respectively).
Three additional minor products were observed in the chain elongation analyses,
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Figure 2.5. Relative formation of GPP and FPP for FPPase and the FI-FI 3 chimeras 
(GPP, geranyl diphosphate; FPP, famesyl diphosphate).
two being the Z-isomers of GPP and FPP, neryl diphosphate (NPP) and Z,/>FPP, 
respectively. Generally, the Z-isomers were produced in low amounts (1-2.5%) by 
enzymes forming a large amount of their E-isomer counterparts. The third minor product 
was identified as a double-bond isomer of GPP, 3-methylene GPP (iGPP).1 Only CPPase 
and the FI chimera were observed to catalyze iGPP formation in relatively low amounts 
( 1-2%).
2.2.2 Enzymatic Products Formed Under Irregular Terpenoid Coupling
Conditions
Enzymatic formation of irregularly coupled terpenoid products was studied in a 
similar manner as the chain elongation products, except the enzymes were incubated with 
3 mM DMAPP at 30 °C overnight (Table 2.2). Formation of irregular isoprenoids by
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Table 2.2. Relative percentages of enzymatic products formed through the irregular 
coupling of two DMAPP molecules (chrysanthemyl diphosphate, CPP; lavandulyl 
diphosphate, LPP; maconelliyl diphosphate, MPP; planococcyl diphosphate, PPP).
CPP LPP MPP PPP
C1 - 66 ± 8 34 ± 8 -
C3 - 63 ± 5 37 ± 5 -
C4 - 48 ± 1 52 ± 1 -
C5 - 47 ± 2 50 ± 1 3 ± 0.6
C6 - 58 ± 1 39 ± 1 3 ± 0.1
C7 - 57 ± 2 40 ± 2 3 ± 0.2
C8 - 56 ± 4 44 ± 4 -
C10 - 57 ± 1 43 ± 1 -
C11 - 94 ± 1 6 ± 1 -
C12 2 ± 0.3 95 ± 1 3 ± 0.4 -
C13 27 ± 0.5 72 ± 1 1 ± 0.1 -
CPPase 77 ± 1 22 ± 0.4 1 ± 0.1 -
F1 64 ± 1 35 ± 1 1 ± 0.2 -
F8 5 ± 0.2 86 ± 1 9 ± 0.8 -
F9 4 ± 0.8 86 ± 1 10 ± 0.3 -
F10 - 84 ± 1 17 ± 1
f_C_f 16 ± 0.7 83 ± 1 1 ± 0.2 -
FPPase, C2, F2-F7, F10-F13, and c_F_c was not detected. For the C1-C10 chimeras, LPP 
and MPP were the major products, generally with a preference towards formation of the 
branched product. The C5-C7 chimeras are unique in that they were the only enzymes 
that produced the cyclobutyl product planococcyl diphosphate (PPP) (Figure 2.6).
A shift in the irregular product ratios occurred at chimera C11, with selective LPP 
formation observed (94% LPP, 6% MPP). The first instance of CPP formation along the 
transformation began at the C12 chimera (1.8% CPP), and the occurrence increased at 
chimera C13 (27% CPP). The cyclopropanation reaction did not out-compete branching 
until complete transformation into CPPase (77% CPP). The F1 chimera maintained 
CPPase-like product ratios, and also exhibited CPP as the major irregular isoprenoid 
product (64% CPP). Significant CPP formation appeared at the expense of MPP, as the 
C12, C13, CPPase, and F1 enzymes only produced the cyclobutyl product in trace
35
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Figure 2.6. Observed product ratios for the enzymes under irregular coupling conditions. 
A. Ratios of irregularly coupled products formed by the C l, C3-C8, and CIO chimeras.
B. Ratios of irregularly coupled products formed by the C l 1-C13, CPPase, F I, and F8-F9 
enzymes (CPP, chrysanthemyl diphosphate; LPP, lavandulyl diphosphate; PPP, 
planococcyl diphosphate; MPP, maconelliyl diphosphate).
relative quantities (< 1% MPP).
In jumping from the F1 to the F8 and F9 chimeras in the CPPase to FPPase, N- to 
C- terminal transformation, LPP returned as the major product (~ 86% LPP), while MPP 
formation restored in preference to, and catalyzed in approximately 2-fold excess over, 
CPP (~ 4.5% CPP, ~ 9.6% MPP). As similarly observed in the chain elongation product 
ratios, the CPPase core-FPPase scaffold chimera showed catalytic specificity analogous 
to chimera C13.
2.3 Michaelis-Menten Kinetic Analyses
2.3.1 Apparent Michaelis-Menten Kinetic Values for the Chain 
Elongation Reaction 
Rates for chain elongation were determined by thin layer chromatography (TLC) 
analysis of product formation in samples from single-point measurements with 32P- 
radiolabeled IPP. Substrates and products were resolved on silica plates, and the 
radioactivity was visualized and quantitated by phosphorimaging (Tables 2.3 and 2.4).
Sagebrush FPPase was unrivaled in the formation of FPP, showing a catalytic 
efficiency relative to GPP of 2.4 (CEGPP, kcatGPP/KMGPP,EA (s'V M '1)), EA indicates 
binding to the electron acceptor site). CEGPP quickly dropped along the N- to C-terminal 
metamorphosis of FPPase to CPPase. Firstly, the C1 chimera showed a 5-fold decrease in 
CEgpp relative to FPPase, with an additional 20-fold drop observed at chimera C2. The 
C2-like CEGPP values were maintained through chimera C6.
At the C6 to C7 transition, a nearly 30-fold drop in CEGPP occurred -  an almost 
4000-fold decrease relative to FPPase. The CEGPP values over the C7-C10 chimeric
36
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Table 2.3. Apparent Michaelis-Menten kinetic values obtained under chain elongation 
conditions using [32P]IPP (EA indicates binding in the electron acceptor site, ED 
indicates binding to the electron donor site).
. DMAPP/IPP 
kcat
v  DMAPP,EA 
KM




V  GPP,EA 
KM
(s'1) (^ M ) (^ M ) (s '1) (^ M )
F P P a se 0 .9 6  ± 0 .0 9 9  ± 2 1 1  ± 3 2 .6  ± 0 .1 0 .8  ± 0 .3
C1 1 .2  ± 0 .1 4  ± 1 1 2  ± 5 1 .5  ± 0 .1 3 .5  ± 0 .9
C2 0 .8 0  ± 0 .0 7 7 4  ± 6 6 0  ± 2 0 0 .8 1  ± 0 .0 5 3 8  ± 7
C3 0 .6 3  ± 0 .0 6 2 0 0  ± 2 0 2 3  ± 7 0 .2 2  ± 0 .0 1 3 6  ± 7
C4 1 .0  ± 0 .1 3 3 0  ± 5 0 3 4  ± 9 0 .2 6  ± 0 .0 1 2 6  ± 4
C5 0 .6 1  ± 0 .0 4 1 1 0  ± 2 0 1 4  ± 3 0 .2 3  ± 0 .0 1 1 6  ± 3
C6 0 .2 3  ± 0 .0 2 2 9  ± 3 8  ± 2 0 .4 2  ± 0 .0 3 2 5  ± 5
C7 0 .1 8 8  ± 0 .0 0 8 1 4 0  ± 2 0 1 1  ± 2 0 .1 4 7  ± 0 .0 0 9 2 4 0  ± 5 0
C8 0 .1 3 2  ± 0 .0 0 6 1 8  ± 2 1 4  ± 2 0 .0 0 7 7  ± 0 .0 0 0 3 6 8 0  ± 7 0
C 10 0 .6 4  ± 0 .0 3 1 2 0  ± 2 0 5 9  ± 1 0 0 .0 1 0  ± 0 .0 0 1 4 0 0 0  ± 8 0 0
C 11 .0 7 0  ± 0 .0 0 6 2 0 0 0  ± 3 0 0 1 3 0 0  ± 4 0 0 - -
C 12 0 .1 1 0 ± 0 .0 0 8 2 3 0 0  ± 3 0 0 1 4 0 0  ± 4 0 0 - -
C 13 0 .0 1 1 1 ± 0 .0 0 0 3 3 5 0  ± 5 0 1 6 0 0  ± 4 0 0 - -
C P P a se 0 .0 0 5 1 ± 0 .0 0 0 2 5 1 0  ± 9 0 1 7 0 0  ± 2 0 0 - -
F1 0 .0 0 1 2 5 9000.00.± 1 5 0  ± 3 0 1 8  ± 2 0 .0 0 0 3 2  ± 0 .0 0 0 0 1 6 .1  ± 0 .9
F8 0 .0 0 2 1 ± 0 .0 0 0 1 1 0 0 0  ± 3 0 0 1 0 0 0  ± 2 0 0 0 .0 0 3 2  (2 4 7  |^M )* -
F9 0 .0 0 9 1 ± 0 .0 0 0 4 1 0 0 0  ± 2 0 0 2 0 0 0  ± 3 0 0 0 .0 0 8 9  (2 4 7  |^M )* -
F 10 0 .0 0 6 7 ± 0 .0 0 0 4 1 4  ± 4 1 1  ± 2 0 .0 0 7 1  ± 0 .0 0 0 4 7  ± 2
F 11 0 .0 0 2 7 ± 0 .0 0 0 1 1 1 0 0  ± 3 0 0 1 6 0 0  ± 3 0 0 0 .0 0 1 7  (2 4 7  |^M )* -
F 12 0 .0 0 1 7 7 6000.00.± 4 4 0  ± 8 0 1 2 0 0  ± 1 0 0 0 .0 0 3 1  (8 2  |^M )* -
F13 0 .0 0 3 7 ± 0 .0 0 0 2 4 0 0  ± 7 0 2 8 0 0  ± 4 0 0 0 .0 0 3 0  (2 4 7  ^ M )* -
c _ F _ c 0 .0 0 8 7 ± 0 .0 0 0 3 5 3 0  ± 7 0 3 3 0 0  ± 3 0 0 0 .0 0 9 7  (2 4 7  |^M )* -
f _ c _ f 0 .0 1 2 ± 0 .0 0 3 2 9 0  ± 5 0 8 0  ± 2 0 - -
*The kcat values indicated are from the average of two experimental samples, with the 
[GPP] maximizing the reaction rate is indicated. KMGPP,EA could not be determined under 
the experimental conditions for the indicated enzymes due to the relatively low GPP and 
high IPP concentrations required to maximize the reaction rate (turnover at low [GPP] 
and high [IPP] was below the detection limit of phosphorimaging techniques).
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Table 2.4. Catalytic efficiencies of the enzymes observed for the chain elongation 
reaction (EA indicates binding to the electron acceptor site, ED indicates binding to the
electron donor site).
. DMAPP/IPP i v  DMAPP,EA 
kcat / k M
. DMAPP/IPP/^ , IPP,ED 
kcat /K m
. GPP f V  GPP,EA 
kcat / k M
(s'1 ^M"1) (s '1 ^M "1) (s '1 ^M"1)
F P P a se 0 .1 0 .0 8 7 3 .3
C1 0 .3 0 .1 0 .4 3
C2 1 .1  x  10"2 1 .3  x  1 0 '2 2 .1  x  1 0 '2
C3 3 .2  x  10"3 2 .7  x  1 0 '2 6 .1  x  1 0 '3
C4 3 .0  x  10"3 2 .9  x  1 0 '2 1 .0  x  1 0 '2
C5 5 .5  x  10"3 4 .4  x  1 0 '2 1 .4  x  1 0 '2
C6 7 .9  x  10"3 2 .9  x  1 0 '2 1 .7  x  1 0 '2
C7 1 .3 4  x  1 0 '3 1 .7  x  1 0 '2 6 .1 3  x  1 0 '4
C8 7 .3  x  10"3 9 .4  x  1 0 '3 1 .1  x  1 0 '5
C 10 5 .3  x  10"3 1 .1  x  1 0 '2 2 .5  x  1 0 '6
C 11 3 .5  x  10"5 5 .4  x  1 0 '5 -
C 12 4 .8  x  10"5 7 .9  x  1 0 '5 -
C 13 3 .2  x  10"5 6 .9  x  1 0 _s -
C P P a se 1 .0  x  10"5 3 .0  x  1 0 _s -
F1 8 .3  x  10"6 6 .9  x  1 0 '5 5 .2  x  1 0 '5
F8 2 .1  x  1 0 '6 2 .1  x  1 0 '6 -
F9 9 .1  x  10"6 4 .6  x  1 0 '6 -
F 10 4 .8  x  10"4 6 .1  x  1 0 -4 1 x  1 0 '3
F 11 2 .5  x  1 0 '6 1 .7  x  1 0 '6 -
F 12 4 .0  x  10"6 1 .5  x  1 0 '6 -
F13 9 .6  x  10"6 1 .3  x  1 0 '6 -
c _ F _ c 1 .6  x  10"5 2 .6  x  1 0 '6 -
f _ c _ f 4 .1  x  10"5 1 .5  x  1 0 -4 -
enzyme transition continually decreased to the point where chimera C10 produced GPP at 
more than 2000-fold greater catalytic efficiency than its Ci5 counterpart. The C11-C13 
chimeras, as well as CPPase, did not produce FPP under the kinetic experimental 
conditions.
The ability to chain elongate to farnesyl diphosphate was immediately recovered 
along the N- to C-terminal, CPPase to FPPase metamorphosis, requiring only the
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replacement of the N-terminal region of CPPase with FPPase. The F1 chimera appeared 
to bind GPP and IPP relatively well (KmGPP,EA of 6.1 pM, KmIPP,ED of 18 pM; ED 
indicates binding to the electron donor site), although substrate turnover was very low 
(kcatGPPIPP of 3.2 x 10-4 s-1) and remained as such throughout the entire CPPase to FPPase 
transformation.
The kinetics regarding chain elongation to GPP mirrored the results observed with 
its C15 counterpart. FPPase and the C1 chimera were the most catalytically efficient GPP 
producers. At chimera C2 an approximately 10-fold decrease in catalytic efficiency 
relative to DMAPP and IPP occurred (CEDmapp, kcatDMAPP/IPP/KMDMAPP,EA (s'1pM‘1); CEIPP, 
kcatDMAPP/IPP/KMIPP,ED (s"1pM '1), respectively), with another 10-fold drop in c e Dmapp 
observed at the C3 chimera. C3-like c e Dmapp and CEIPP levels were maintained along the 
FPPase to CPPase chimeric enzyme transformation up through chimera C10. A drastic 
change occurred at the C10 to C11 chimeric enzyme transition, where c e Dmapp and CEIPP 
decreased over 150-fold. The relatively low-level, C11-like production of GPP was 
essentially maintained throughout the remainder of the CPPase to FPPase transformation.
2.3.2 Apparent Michaelis-Menten Kinetic Values for the Irregular
Coupling Reaction
All enzymes turning over two DMAPP molecules exhibited low catalytic rates 
and high KmDmapp relative to CPPase and C13 (Table 2.5). CPPase and C13 were 
comparable in their irregular coupling ability, averaging a catalytic efficiency of 5.0 x 10' 
6 s’VM -1. The KmDmapp values obtained under chain elongation and irregular coupling 
conditions significantly differed for chimera C13 and CPPase. As a result, it is concluded
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Table 2.5. Rates of irregular product formations observed at 6 mM DMAPP spiked with 
[32P]DMAPP for the C1, C3-C8, C10-C12, F1, F8-F10, and f_C_f chimeras, and the 
apparent Michaelis-Menten parameters of CPPase and the C13 chimera (ED indicates
binding in the electron donor site).
kcat
(6  m M  D M A P P, s"1)
C1 3 .7 1  x  1 0 -4
C3 6 .9 2  x  1 0 -4
C4 5 .0 2  x  1 0 -4
C5 1 .0 7  x  1 0 '3
C6 6 .5 8  x  1 0 -4
C7 9 .5 0  x  1 0 -4
C8 3 .9 5  x  1 0 -4
C 10 9 .6 0  x  1 0 -4
C 11 8 .5 5  x  1 0 -4
C 12 5 .9 4  x  1 0 -4
F1 1 .8 9  x  1 0 '3
F8 3 .1 7  x  1 0 '5
F9 2 .9 7  x  1 0 -4
F 10 6 .3 4  x  1 0 -4
f _ c _ f 1 .7 8  x  1 0 '3
C 13
C P P a se
. DMAPP 
kcat




(s '1) (^ M ) (s"1^ M _1)
0 .0 1 0 9  ± 0 .0 0 0 5 2 1 0 0  ± 2 0 0 5 .2  x  1 0 '6
0 .0 1 9 5  ± 0 .0 0 0 8 4 1 0 0  ± 4 0 0 4 .8  x  1 0 '6
respectively, under regular coupling conditions are representative of DMAPP binding to 
the electron acceptor site of the enzymes, consistent with the chain elongation 
reaction,whereas the KMDMAPP values of 2100 ^M and 4100 ^M for C13 and CPPase 









Amino acid residues in the five conserved regions of E-chain elongation enzymes 
form the active sites of sagebrush FPPase and CPPase with few exceptions (Table 3.1). 
Four milestones along the N- to C-terminal transformation of FPPase to CPPase occur. 
First, increases of KmDmapp,ea, Kmipp,eD, and KMGPP,EA were observed at the C1 to C2 
chimeric enzyme transition. The second milestone is marked by the transitioning of chain 
elongation activity from preferential FPP (C15) formation to GPP (C10) at chimera C10 
due to an increase of KMGPP,EA. The third milestone appears at the C10 to C11 transition, 
where a decrease in kcatDMAPP/IPP, an increase in KmDmapp ea, and an increase in Kmipp,eD 
occur. Finally, the fourth milestone involves the appearance of significant irregular 
coupling ability at chimera C13, indicating the appearance of a CPPase-like allowance of 
DMAPP binding to the electron donor site.
Along the N- to C-terminal conversion of CPPase to FPPase, selective binding of 
IPP to the electron donor site, and thus catalytic propensity towards the chain elongation 
reaction, was regained at the F1 chimera, followed by the loss of competitive irregular 
coupling ability at chimera F2. Interestingly, an FPPase-like catalytic efficiency was not 
restored at any point in the CPPase and FPPase transition.
43
Table 3.1. Direct and indirect residue-substrate interactions observed in molecular 
models of sagebrush FPPase and CPPase (IPP bound in the electron donor site, DMASPP 

































Substrate-bound molecular models of the parental enzymes and select chimeric 
constructs were built using an apo C3 structure (Brookhaven pdb 4KK2) and an E. coli 
FPPase structure binding IPP and an unreactive substrate analogue of DMAPP 
(Brookhaven pdb 1RQI, thioDMAPP or DMASPP). The E. coli structure was used as a 
template to morph the C3 structure to the catalytically relevant closed conformation, and 
to model IPP and DMASPP bound in the active site. The molecular models provide 
structural insights into how particular mutations alter the active site topologies of the 
enzymes, and therefore their catalytic specificities and efficiencies. The mutations 
correlating with events in the chimeric enzyme transitions, and their structural 
implications, are discussed in this chapter.
3.2 Structural Implications of the N-terminal Region in the Binding and 
Turnover of Isoprenoid Substrates
As exemplified by the C1 and F1 chimeras, the N-terminal portion outside the IS- 
1 fold of the sagebrush enzymes influences their activities and specificities. FPPase N- 
terminal sequence appeared to promote GPP and selective IPP binding capabilities of the 
enzymes, and thus their propensities toward the chain elongation reaction. Structurally, 
the N-terminal region of the sagebrush enzymes consist of two a-helices running 
perpendicular to the IS-1 fold, proximal to helices I, II, and III from the same monomer 
(A), and to helix V of the other monomer (B).
In FPPase and CPPase molecular models, residues from monomer A in the loop 
between the two N-terminal helices form hydrogen bonding interactions with residues in 
helix Va(B) near the fourth conserved region of E-chain elongation enzymes (E30-
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R188(B), E30-Q191(B), D32-R188(B), and D33-Y192(B)). Residue K193 from the 
fourth conserved region assists in binding the allylic substrate to the electron acceptor site 
of the enzymes. Mutations of the N-terminal region may produce structural differences 
affecting the cross-monomer hydrogen bonding interactions, which in turn may have a 
cascade effect altering the position and dynamics of K193 in the electron acceptor site. 
This alteration of the electron acceptor site may be responsible for the KMGPP ea increase 
observed with the FPPase to chimera C1 transition.
The L52M FPPase to CPPase mutation is located in the N-terminal and first 
conserved E-chain elongase region of the enzymes, which form a portion of the electron 
donor site. Although molecular models show the L52M residues pointing away from 
substrate, their size difference may create unique steric interactions influencing the 
position of the nearby K51, N53V, and R54 residues, which do point toward and interact 
with substrate bound to the electron donor site. The positioning of residues of the first 
conserved region is a likely determinant in the selective binding of IPP to the electron 
donor site. In this, it is possible the steric influence of the L52M mutation is influential in 
the Kmdmapp,ed increase and KMIPP,ED decrease associated with the CPPase to F1 chimera 
transition.
3.3 The Loss of Catalytic Activity at the C2 Chimera 
The transformation from the C1 to the C2 chimera was marked by a significant 
loss in catalytic efficiency for formation of chain elongation products, greatly in part from 
KMDMAPP,EA, KmGPP,ea, and KmIPP,ed increases. An N53V FPPase to CPPase active site 
mutation is associated with chimera C2. As mentioned earlier, N53 indirectly coordinates
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IPP in the electron donor site through a water molecule, accompanying the 
aforementioned K51 and R54 as the residues from the first conserved region responsible 
for binding substrate to the electron donor site (Figure 3.1). The N53V mutation may 
decrease the affinity of IPP for the site simply due to the loss of a residue-substrate polar 
interaction, in addition to potential steric and dynamic affects.
3.4 The Transformation from FPPase to GPPase Activity at the
C10 Chimera
Enzymes chain elongating to FPP must accommodate the C10 hydrophobic chain 
of GPP. The pocket binding the aliphatic chain of GPP is formed by helices II, IV, and 
the Va,b kinked pair of the sagebrush IS-1 fold, and to a lesser degree helix III(B). The 
GPP binding pocket is altered along the N- to C-terminal, FPPase to CPPase 
transformation in a manner that increased KMGPP,EA, to the point that GPP binding was all 
but lost at the C10 chimera. The increase of KMGPP,EA along the chimeric enzyme 
transition appears to be the result of a synergistic effort from several mutations involving 
the helices forming the GPP binding pocket.
The decline from C2-like CEGPP began at the C7 chimera, which exhibited an 
approximately 10-fold increase in KMGPP,EA and 3-fold loss in kcatGPP/IPP relative to 
chimera C6. The C6-C7 chimeric transition is associated with an R141Q FPPase to 
CPPase mutation. R141 (in the helix III-IV loop region) appears to form two cross­
monomer polar contacts, hydrogen bonding with D148(B) and D152(B) of helix IV(B) -  
an interaction lost with the R141Q mutation. At the C8 chimera the rate of FPP formation 
further decreased and KMGPP,EA further increased. Two mutations correlate with the C7-
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Figure 3.1. Images highlighting residues K51, N53V, and R54 of the first conserved 
region of E-chain elongation enzymes, which assist in binding substrate to the electron 
donor site. Magnesium ions are shown. The hydrogen-bonding interactions (yellow 
dashes) observed in FPPase (A, green) and CPPase (B, cyan) between the residues, an 
active site water, and IPP. C. Structural overlap of FPPase and CPPase.
C8 transition, A161I and L168T, which appear to alter steric interactions between helix 
IV and helices III and II(B), respectively. The A161I and L168T mutations surround the 
third conserved E-chain elongation region, which contain residues (Q164 in CPPase and 
C10, D167 in FPPase) that participate in binding allylic substrate to the electron acceptor 
site.
Along the C8 to C10 transition, GPPase activity solidified, with C10 exhibiting a 
more than 2000-fold catalytic efficiency toward GPP production over FPP, and doing so 
with a kcatDMAPP/IPP comparable to FPPase. Two active site changes are associated with the 
C8 to C10 chimeric transition, T171R and H186N. Molecular models reveal that R171 of 
the C10 chimera inserts into the active site and participates in binding allylic substrate. In 
FPPase, H186 forms a polar interaction with D236 of the second DDxxD motif, perhaps 
providing structural stability to the electron acceptor site in a way conducive to binding 
GPP. FPPase and the C10 chimera show unique active site topologies revolving around 
D167 and the T171R mutation. In FPPase, D167 forms structural hydrogen bond 
interactions with K258 and K193, whereas in C10 residue D167 interacts with R171 and 
K193 (Figure 3.2).
It is known that mutations of the GPP binding pocket can introduce or remove 
steric interferences defining the length of chain an enzyme can bind, and therefore 
determine the chain length of the final product.1,2 Comparison of FPPase and C10 
molecular models reveal no obvious reason for the loss of GPP binding. Instead, it 
appears that a culmination of structural components define the nature of the GPP binding 
pocket, and thus the catalytic selectivity of a sagebrush enzyme.
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Figure 3.2. Images illustrating the structural differences between the electron acceptor 
binding site of FPPase (A, green) and the C10 chimera (B, yellow) due to the T171R 
mutation (hydrogen bonds indicated by dashed yellow lines). C. Structural overlap of 
FPPase and chimera C10. Mg2+ ions and relevant active site waters are shown.
3.5 The Significance of the T194G Mutation 
The “KT m otif’ is composed of residues K193 and T194G (FPPase to CPPase 
mutation), which reside in the fourth conserved region among E-prenyl chain elongation 
enzymes. The fourth conserved region marks the “kink” in the Va,b helical kinked pair in 
the sagebrush IS-1 fold. FPPase and CPPase molecular models show K193 indirectly 
binding DMASPP to the electron acceptor site through water. Exploration of the role of 
the KT motif prompted the placement of the tenth chimeragenesis crossover point at its 
heart, effectively isolating the T194G mutation in the C10-C11 chimera transition.
In the molecular model of FPPase T194 forms a hydrogen bond with G228. The 
interaction links the Va,b helical kinked pair to helix VI, and therefore essentially the 
fourth and fifth conserved regions. The fifth conserved region contains the second 
DDxxD motif, partially responsible for binding the electron accepting allylic substrate 
through Mg2+ mediated interactions. The T194-G228 contact appears to play a significant 
role in the ability of the sagebrush enzymes to bind and condense terpenes, as exhibited 
by an approximately 10-fold reduction in kcatDMAPP/IPP and 20-fold increase in KmDmapp,ea 
and Kmipp,eD at the C10 to C11 transition. It appears the T194-G228 interaction provides 
a structural anchor to the active site, assisting to position the fourth and fifth conserved 
regions in a manner essential to maintaining the catalytic efficiency of the enzymes 
(Figure 3.3).
3.6 The Influence of the F231Y and D235N Mutations 
The F231Y and D235N amino acids reside in the fifth conserved region of E- 
chain elongases. These active site mutations correlate to the C13 chimera in the N- to C-
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Figure 3.3. FPPase (green) and chimera C11 (salmon) structural overlaps highlighting 
the T194-G228 hydrogen bond (yellow dashes) in FPPase that is lost at C11 due to a 
T194G mutation. Also shown is K193 of the KT motif, residues D235 and D239 of the 
second DDxxD motif, and magnesium ions.
terminal conversion of FPPase to CPPase -  the chimeragenesis point at which DMAPP 
competes with IPP in binding the electron donor site.
As revealed by molecular models, the F231Y mutation sterically and polarly 
interacts with the diphosphate moiety of substrate bound to the electron donor site. The 
D235N mutation appears to introduce a steric barrier in the electron donor site near the 
methylene carbon of IPP from the re face. This steric interaction forces IPP to rotate 
along the C2-C3 bond axis and adopt a smaller C1-C2-C3-C4 (methylene carbon as C4) 
dihedral angle (FPPase, 73.5°; CPPase, 53°). Interestingly, the F231Y and D235N 
mutations coerce the aliphatic portion of IPP into a more planar, DMAPP-like 
conformation -  a sign very telling of their significance in creating an electron donor site 
suitable for DMAPP binding (Figure 3.4).
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Figure 3.4. Images highlighting the influence of the F231Y and D235N mutations on the 
active site of the enzymes. A. Residues F231 and D235 in FPPase (green). B. Residues 
Y231 and N235 in the C13 chimera (magenta). C. Structural overlap of FPPase and 
chimera C13 illustrating the steric effects the mutations have on IPP positioning and 
conformation. D. C13 structural overlaps with IPP (magenta) and DMAPP (orange) 
bound in the electron donor site. Magnesium ions are shown.
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LPP Formation
A common mechanism is utilized in the enzymatic catalysis of the fundamental 
irregular couplings.2 Initiation of the irregular coupling reaction begins with the 
diphosphate moiety from DMAPP bound in the electron acceptor site (DMAPPea) 
leaving to form the dimethylallyl cationic intermediate (DMA+). The DMA+ intermediate 
then electrophilically alkylates the double bond of DMAPP bound in the electron donor 
site (DMAPPeD), forming a protonated cyclopropyl chrysanthemyl cationic intermediate 
(C+). C+ lies at the first branch point in the irregular coupling mechanism, where the flux 
between CPP and LPP formation is regulated. The C+ intermediate can either be 
quenched by proton extraction (presumably by the well-positioned leaving diphosphate) 
to form CPP, or undergo cationic rearrangement to form the branched, lavandulyl cation 
(L+). The L+ intermediate may further rearrange to form cationic cyclobutyl 
intermediates, or be quenched by proton extraction to form LPP. Notably, molecular 
models of the C13 chimera indicate that the nonleaving diphosphate (from DMAPPeD) is 
better positioned to quench L+ than the leaving diphosphate (2.6 A and 5.1 A, 
respectively) (Figure 3.5).
The ratio of CPP and LPP formation in the sagebrush enzymes depends upon the 
rate of proton extraction from C+ to form CPP versus the rate of C+ rearrangement to L+, 
respectively (Scheme 3.1).3 In the case of CPPase, proton extraction from C+ occurs more 
quickly than rearrangement to L+; conversely, rearrangement to L+ occurs more quickly 
in the C13 chimera. The relative rates of proton extraction from, and rearrangement of C+ 
partially depend upon the ability of the enzymes to stabilize the C+ and L+ cationic
3.7 The CPPase and C13 Enzymes -  Preferential CPP versus
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DMASPPEA
Figure 3.5. The nonleaving diphosphate from DMAPPed is better positioned at 2.6 A to 
quench the lavandulyl cationic intermediate than the leaving diphosphate from DMAPPEA
at 5.1 A in chimera C13.
intermediates through enzyme-substrate polar interactions.4 CPPase and C13 differ by 
three active site residues -  F247I, E256D, and G343R (mutations written CPPase to 
C13). The F247I mutation does not appear to have a significant role. In contrast, R343 in 
the C13 chimera is positioned to polarly interact with the diphosphate of DMAPPed, 
which, in turn, is positioned to provide proximal negative charge to the stabilization of 
L+. In this, R343 may limit the movement of the nonleaving diphosphate, keeping it 
better positioned to stabilize the branched carbocation, and thus promote its formation.
If the leaving diphosphate is responsible for quenching C+, and therefore CPP 
formation, positioning of the diphosphate relative to C3-C+ is important in defining the 
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Scheme 3.1. Catalytic sequence employed by the sagebrush IS-1 enzymes in the 
formation of chrysanthemyl diphosphate (CPP) and lavandulyl diphosphate (LPP). The 
ratio of CPP versus LPP formation is dependent upon the rates of proton extraction from 
the chysanthemyl cation (C+) versus rearrangement of C+ to the lavandulyl cation (L+).
formation of C+, pushing the hydrogens to the same face as the leaving diphosphate. The 
closer the leaving diphosphate remains to the carbon it was once bonded with, the more 
efficiently it can extract the newly proximal proton from C3-C+ and drive the mechanistic 
flux towards CPP formation. In accordance with the hypothesis, molecular models reveal 
that the leaving diphosphate is closer to the C+ quenching proton in CPPase than C13 (2.7 
A versus 3.5 A, respectively) (Figure 3.6).
The CPPase and C13 molecular models also reveal the significance of the E256D 
mutation in altering the electron acceptor site. In CPPase, E256 indirectly coordinates the 
leaving diphosphate through two water molecules, whereas D256 in the C13 chimera 
forms residue-residue polar contacts with T252, K258, and K285. Apparently the active
L+
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Figure 3.6. Images highlighting the distance between leaving diphosphate and the proton 
extracted to quench the cyclopropyl cationic intermediate (C+) to form chrysanthemyl 
diphosphate (CPP) in the CPPase (blue, 2.7 A) and C13 (magenta, 3.5 A) enzymes.
Magnesium ions are shown.
site polar interactions involving K258 depend upon whether glutamate or aspartate 
occupies position 256. Instead of hydrogen bonding with D256, as observed in chimera 
C13, K258 in CPPase forms polar residue-residue contacts with D167, T168, and the 
backbone of R171, effectively linking the C-terminal and third conserved E-chain 
elongase regions. Residue Q164 of the third conserved region sterically interacts with the 
aliphatic portion of DMAPPEA, and in turn is a likely factor in determining the relative 
positions of C3-C+ and leaving diphosphate. It is possible the presence or absence of the 
K258-third conserved region connection influences the Q164-DMAPPEA interaction. If 
so, not only does the E256D mutation itself potentially influence the relative positions of 
C3-C+ and leaving diphosphate, but also through altering the Q164-DMAPPEA interaction 
through K258 (Figure 3.7). Regardless, the E256D mutation appears to be a prime 
determinate in regulating the flux of CPP and LPP formation.
3.8 The Enigmatic F10 Chimera 
The F9 to F10 chimeric enzyme transition showed drastic decreases in 
KMDMAPP,EA and Kmipp,ed. Comparing CPPase and F10 molecular models do not yield any 
obvious explanations for the isolated shift in substrate binding. If anything, the F10 
chimera is a testament to the dynamic personality of the sagebrush IS-1 fold, where 
mutations distal from the active site can have consequences altering the catalytic 
characteristics of the enzymes.
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Figure 3.7. Molecular models of CPPase (A, blue) and chimera C13 (B, magenta) 
showing the differences in their electron acceptor sites due to the E256D mutation. C. 
Structural overlap of CPPase and C13 molecular models. Magnesium ions are shown.
3.9 The Significance of the C-terminus 
Sagebrush FPPase is a well-evolved enzyme designed for the biosynthesis of FPP. 
It is apparent that sagebrush FPPase provides a genetic template for duplication and 
mutation, and in doing so produced the catalytically diverse CPPase. Despite the 
astounding sequential, and therefore structural, similarity of the enzymes, swapping 
homologous regions between them significantly alters their catalytic properties. None of 
the chimeric enzymes produced FPP as efficiently as parental FPPase, and similarly, 
CPPase was the most efficient CPP producer, demonstrating the astonishing capacity of 
nature to develop and select catalysts.
As discussed above, replacing the C-terminal region of CPPase with FPPase 
sequence shifted the irregular coupling product ratios, producing an LPPase. Markedly, 
along the N- to C-terminal conversion of CPPase to FPPase, FPPase-like activity was not 
restored at any point. In fact, enzymes with C-terminal sequence from CPPase are some 
of the most catalytically inefficient enzymes studied, accompanying enzymes with the 
T194G mutation. Clearly the C-terminal region outside of the IS-1 fold is crucial in 
defining the catalytic nature of a sagebrush enzyme. As exemplified in the CPPase/C13 
discussion, notable active site mutations in the C-terminal region are D256E and R343G 
(FPPase to CPPase). Residue E256 in CPPase participates in binding allylic substrate to 
the electron acceptor site, whereas R343 in FPPase assists in binding substrate to the 
electron donor site (Figure 3.8). These C-terminal mutations also have the potential to 
influence the catalytic efficiency of the chain elongation reaction due to their unique 
contributions in defining the active site. Regardless of whether or not the two active site 
mutations are fully responsible for the influence of the C-terminus, the region appears as
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Figure 3.8. Images highlighting the influence of the D256E and R343G FPPase to 
CPPase C-terminal mutations (A, FPPase, green; B, CPPase, cyan). C. FPPase and 
CPPase structural overlaps. Magnesium ions are shown.
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one of the most significant determinants in defining the catalytic activity and specificity 
of the sagebrush enzymes.
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A polymerase chain reaction (PCR) method was developed to efficiently build 
chimeric gene constructs from Artemisia tridentata spp. spiciformis (sagebrush) farnesyl 
diphosphate synthase (FPPase) and chrysanthemyl diphosphate synthase (CPPase) genes. 
PCR was the method of choice for chimeragenesis, allowing for the selective placement 
of crossover points and retention of native parental enzyme sequences. Thirteen crossover 
points were used to build the chimeric gene constructs in regard to the IS-1 fold, with one 
enzyme turned into the other through sequentially swapping the a-helices and loops of 
the fold. The chimeric gene construct began with the N-terminal sequence from one 
parental enzyme up to one of thirteen crossover points, at which point the sequence 
changes to the other enzyme, and continued as such through the remainder of the 
construct. To fully assess the influence of the enzymatic structure outside of the IS-1 fold, 
two additional “core-scaffold” chimeras were built. The additional proteins consisted of 
the IS-1 fold region from one enzyme (core) with the N- and C-terminal regions of the 
other.
4.1.2 Cloning of Sagebrush FPPase and CPPase Genes into pET15b
4.1.2.1 Supplementary Cloning Materials and Procedures
4.1.2.1.1 Luria Broth and Agarose Preparation
Luria broth (LB) media was prepared by combining 10 g of tryptone (Fisher- 
Scientific), 5 g yeast extract (Becton Dickinson Biosciences), and 10 g NaCl (Fisher 
Scientific) in 1 L of deionized (DI) water. LB agarose was made similarly to LB media, 
with the addition of 15 g of agar (Fisher Scientific). The LB solution was sterilized by 
autoclaving. In the case of LB agarose preparation, the autoclaved solution was allowed 
to cool to room temperature (rt) to 50-55 °C, at which point Ampicillin was added at a 
concentration of 100 p,g/mL (LB+Amp). LB agarose containing Ampicillin was poured 
into plates and left overnight at rt to solidify, and then stored at 4 °C. After a one-month 
period, unused LB+Amp agarose plates were discarded. LB solution was stored at rt until 
used, with Ampicillin added upon use if antibiotic selection was required.
4.1.2.1.2 Gel Electrophoresis Separation of DNA
A 50X stock solution of Tris-acetate-EDTA (TAE) buffer was prepared by adding 
242 g of Tris base to 750 mL of DI water. Then 57.1 mL of glacial acetic acid was added, 
followed by 100 mL of 0.5 M EDTA (pH 8.0). DI water was then used to bring the final 
volume to 1 L and the solution stored at rt. The final buffer solution had a pH of 
approximately 8.5.
To prepare the electrophoresis gel, 1.5 g of agarose was added to 150 mL of TAE 
buffer. The mixture was microwaved to boiling, and then mixed to completely dissolve 
the agarose. Before casting the TAE agarose solution, 1.5 ^L of 10,000X SYBR Safe
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DNA Gel Stain (Life Technology) was added in order to visualize the DNA bands. The 
DNA fragments were separated by applying 125 V in TAE buffer until the orange dye 
band (approximately 50 bp) from the 6X Blue/Orange DNA Loading Dye (Promega) 
reached the bottom of the gel. A GeneRuler 1 kb DNA Ladder (Thermo Scientific) was 
used to estimate the basepair length of sample DNA bands, with the DNA fragments 
being visualized using a Dark Reader Transilluminator (Clare Chemical).
4.1.2.1.3 Preparation of Chemically Competent DH5a Cells
All materials (centrifuge tubes, bottles, solutions, etc.) used in the preparation of 
the cells were sterilized by autoclave. A frozen glycerol stock of DH5a cells was used to 
inoculate 1 mL of LB media, and the sample shaken at 225 rpm and 37 °C overnight. The 
entire 1 mL culture was then used to inoculate 500 mL of LB, and the sample shaken at 
225 rpm and 37 °C until the optical density at 550 nm (OD550) reached 0.45-0.6 (~ 4 h). 
The 500 mL culture was then transferred in 250 mL portions to two 500 mL centrifuge 
tubes and chilled to 4 °C. The samples were then centrifuged at 6,000 g for 5 min at 4 °C, 
and then the supernatant removed. Each cell pellet was then resuspended in 125 mL of 
ice-cold 50 mM CaCl2, and the samples combined into a single 500 mL centrifuge bottle. 
The sample was then centrifuged at 6,000 g for 5 min at 4 °C. After centrifugation, the 
supernatant was poured off and then the cell pellet was resuspended in 21.5 mL of ice- 
cold 50 mM CaCl2. After cell resuspension, 3.5 mL of glycerol was added to the sample 
and the solution gently mixed. The cell suspension was aliquotted into sterile 1.7 mL 
microcentrifuge tubes in 500 ^L portions, flash frozen using liquid nitrogen, and then 
stored in a -80 °C freezer until use.
4.1.2.1.4 Transformation of DNA into Chemically Competent DH5a Cells
A frozen glycerol DH5a cell stock was thawed on ice. After thawing, a 100 ^L 
portion(s) of the cell stick was transferred to 1.7 mL microcentrifuge tubes on ice. A 1 ^L 
portion of plasmid DNA was added to the cells and the sample incubated on ice for 20-25 
min. The sample was then heat shocked by placement in a 42 °C water bath for 45 s, and 
then promptly returned to ice. A 1 mL portion of Super Optimal broth with Catabolite 
repression (SOC medium, Invitrogen) was added, and after which the sample transferred 
to a 14 mL polystyrene or polypropylene Falcon round-bottom tube(s) (Fisher Scientific) 
and shaken at 225 rpm and 37 °C for 1 h. Aliquots of 2, 20, and 200 ^L were then plated 
on LB+Amp agarose and the plates incubated overnight at 37 °C.
4.1.2.1.5 Restriction Endonuclease Digestion of Plasmid DNA
Plasmid DNA used for restriction enzyme-based cloning was always “doubly 
digested,” which is digestion by two restriction enzymes at a time. The restriction 
endonucleases used to clone the sagebrush genes into pET15b were FastDigest Ndel, 
BamHI, and Mva1269I (Thermo Scientfic). A 1 ^L portion of each enzyme was used to 
doubly digest 10 p,g of plasmid DNA in a total volume of 20 ^L at 37 °C for 1 h. Thermo 
Scientific’s proprietary FastDigest Green Buffer was used in each reaction.
4.1.2.1.6 Miniprep and Midiprep Purification of Plasmid DNA from 
Cell Cultures
To prepare a cell culture for the miniprep purification of plasmid DNA, a single 
cell colony was used to inoculate 5 mL of LB+Amp media. The inoculated media was
65
then shaken at 225 rpm and 37 °C overnight. The plasmid DNA was purified from the 5 
mL overnight culture using a QuickClean 5M Miniprep Kit (GenScript).
To prepare a cell culture for midiprep purification, 1 mL of LB+Amp was 
inoculated, as described above, and shaken in a water bath at 225 rpm and 37 °C for 6-8 
h. Following the incubation, 50 ^L of the preculture was used to inoculate 50 mL of 
LB+Amp, and the 50 mL inoculation was shaken at 225 rpm and 37 °C overnight. The 
plasmid DNA was then purified from the 50 mL culture using a CompactPrep Plasmid 
Midi Kit (Qiagen).
4.1.2.1.7 Purification of DNA Bands from Agarose
DNA was purified from polymerase chain reactions and gel electrophoresis 
experiments using an illustra GFX PCR DNA and Gel Band Purification Kit (GE Life 
Science).
4.1.2.1.8 Transformation of Plasmid DNA Into XL10 Gold 
Ultracompetent Cells
After thawing on ice, a 30 ^L portion of XL10 Gold ultracompetent cells 
(Stratagene) was pipetted into an ice-cold 1.7 mL microfuge tube. Then a 1.2 ^L aliquot 
of the provided P-mercaptoethanol (P-Me) solution was added to the sample and the tube 
swirled gently. The sample was then incubated on ice for 10 min, with gentle swirling 
every 2 min. A 3 ^L portion of plasmid DNA was then added to the cells, the tube gently 
swirled, and the sample incubated on ice for 30 min. The sample was then heat-pulsed by 
placement in a 42 °C water bath for 30 s, and then promptly removed and incubated on
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ice for 2 min. A 200 ^L portion of SOC medium was then added and the sample shaken 
in a water bath at 225 rpm and 37 °C for 1 h. After shaking, a 2-200 ^L portion of the cell 
culture was pipetted onto LB+Amp agarose plates and incubated overnight at 37 °C.
4.1.2.2 Preparation of NdeI and BamHI Restriction Enzyme Digestions of 
Sage FPPase and CPPase Genes
The DNA sequences for sagebrush FPPase and CPPase genes were synthesized in 
E. coli context by GenScript and obtained as NdeI/BamHI inserts in the plasmid pUC57. 
The pUC57-FPPase and pUC57-CPPase plasmids were chemically transformed into 
DH5a cells. Then minprep purifications were performed on the pUC57-gene-DH5a 
samples to obtain working stock solutions of pUC57-FPPase and pUC57-CPPase. NdeI 
and BamHI restriction enzyme digestions were performed on 10 p,g of pUC57-FPPase 
and pUC57-CPPase, and the DNA fragments were separated by gel electrophoresis. DNA 
bands corresponding to the genes (~ 1375 base pairs (bp)) were excised from the gel, 
purified, and stored at -20 °C until needed.
4.1.2.3 Preparation of NdeI/Mva1269I and BamHI/Mva1269I 
Digested pET15b
It proved difficult to purify NdeI/BamHI digested pET15b from undigested 
plasmid, as the excised DNA fragment produced by the digestion is only 12 bp long. In 
order to separate NdeI- and BamHI-digested pET15b, a third restriction enzyme was 
used. A 10 p,g portion of pET15b was submitted to NdeI/Mva1269I and 
BamHI/Mva1269I double digestions. The DNA gel electrophoresis band showing a
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length of approximately 3017 bp from the NdeI/Mva1269I digestion, and the band 
showing a length of approximately 2391 bp from the BamHI/Mva12691I, were gel 
purified and stored at -20 °C until needed.
4.1.2.4 Production of pET15b Containing Sagebrush FPPase and CPPase 
Ndel/BamHI Inserts
New England Biolabs’s (NEB) Quick Ligation Kit was used for the 3-piece 
ligation. A 3 ^L portion (each) of the Ndel/BamHI digested gene (obtained from the 
pUC57-gene digestions), the DNA fragment purified from the NdeI/Mva12691I digestion 
of pET15b, and the DNA fragment purified from the BamHI/Mva12691I digestion of 
pET15b were combined in a 1.7 mL microfuge tube. A 10 ^L portion of the 2X Quick 
Ligation Buffer and 1 ^L portion of the Quick T4 DNA Ligase was added and the 
solution thoroughly mixed. The sample was then briefly centrifuged and incubated at rt 
for 30 min. After the ligation reacton, the sample was transformed into XL10 Gold 
ultracompetent cells, plated on LB+Amp agarose, and incubated overnight at 37 °C. A 
miniprep was then performed on 5 colonies and the purified plasmid DNA screened for 
ligation product via gel electrophoresis -  a band showing a length of approximately 7083 
bp indicated the formation of the pET15b-gene product. Sanger DNA sequencing by the 
University of Utah DNA Sequencing core, using universal T7 forward and reverse 
primers, verified pET15b-FPPase and pET15b-CPPase constructs.
4.1.3 Construction of Chimeric Genes Using the Polymerase
Chain Reaction
4.1.3.1 Introduction
The method used to construct the chimeric protein genes was based upon 
megaprimer whole plasmid (MEGAWHOP) and structure-based combinatorial protein 
engineering (SCOPE) polymerase chain reaction (PCR) techniques. 1,2 The genes were 
assembled through two rounds of PCR using PfuUltra II Fusion HS DNA polymerase 
(Agilent) and an MJ Research PTC-200 PCR thermal cycler. The first reaction used a 
forward primer and a “crossover” reverse primer to construct a megaprimer, which 
contains the coding region for the N-terminal sequence of the chimeric protein. The 
second reaction completes the crossover from one enzyme’s DNA sequence to the other, 
building the remaining C-terminal sequence onto the megaprimer and finalizing the 
chimeric gene construct in pET15b.
All primers were designed using Integrated DNA Technologies’ OligoAnalyzer to 
calculate their melting temperatures and synthesized by University of Utah’s 
DNA/Peptide Synthesis core. In the case of the crossover primers, each half was designed 
with a 60 °C melting temperature. The forward primers were designed from N-terminal 
CPPase and FPPase to have a 60 °C melting point, with a 20 base pair sequence of 
complementary pET15b sequence added to the 5’ end to assist megaprimer binding in the 
second PCR reaction.
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4.1.3.2 Polymerase Chain Reactions Employed in the Construction 
of Chimeric Genes
For the first reaction, 50 ng of vector template (pET15b-gene), 250 ^M 
deoxynucleotides (dNTPs), 200 nM of the forward primer (dependent upon whether 
FPPase or CPPase is the template gene), 200 nM of the reverse “crossover” primer, 10 
^L of the proprietary PfuUltra II 10X reaction buffer, and 2 ^L of PfuUltra II were 
combined in a total volume of 100 ^L. The samples were then heated to 95°C for 2 min, 
followed by 30 cycles of 95°C for 30 s, 55°C for 30 s, 72°C for 21 s, with an additional 
final extension at 72°C for 3 min. The sample was then cooled to 4 °C, and the 
megaprimer purified by gel electrophoresis.
For the second reaction, 120 ng of template DNA (appropriate pET15b-gene), 250 
^M dNTPs, 5 ^L of PfuUltra II 10X reaction buffer, 1 ^L of PfuUltra II, and the 
appropriate amount of purified megaprimer to bring the total volume to 50 ^L, were 
combined. The thermocycle program for the second reaction was the same as the first, 
except the time for the 72 °C primer extension phase was extended to 1 min 47 s to allow 
the complementary strand for the entire plasmid to be synthesized.
To cut the template DNA, the PCR reaction solution was submitted to FastDigest 
Dpnl (Fermentas) digestion by adding 7 ^L of the FastDigest Green Buffer, 7 ^L of 
DpnI, and 6  ^L of DI water. The reaction solution was mixed and incubated at 37 °C for 
1 h. Following DpnI digestion, 3 ^L of the mixture was transformed into 30 ^L of XL10 
Gold cells, with 20 and 200 ^L portions plated on LB+Amp agarose plates. After 
incubating the plates overnight at 37 °C, minipreps were performed on 5 colonies. The 
purified plasmid DNA was screened via gel electrophoresis, and samples showing proper
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size (~ 7083 bp) were screened by Sanger DNA sequencing. Samples showing 
production of the desired chimeric gene were stored at -80 °C (Figure 4.1).
4.2 Expression and Purification of Enzymes
4.2.1 Supplementary Materials and Methods
4.2.1.1 Stock Solutions
Deionized water was used in the preparation of all solutions. After preparation, 
the solutions were sterilized by autoclave, unless indicated otherwise.
4.2.1.1.1 Preparation of 50X 5052 Solution
A 1X 5052 solution contains 0.5% glycerol, 0.05% glucose, and 0.2% a-lactose. 
To make 100 mL of 50X 5052 solution, 25 g of glycerol was added to 73 mL of water 
and the solution mixed. Then, a 2.5 g portion of glucose and a 10 g portion of a-lactose 
monohydrate were added and the solution mixed. The solution was then heated by 
microwave to facilitate dissolution.
4.2.1.1.2 Preparation of ZY Broth
Adding 10 g of tryptone and 5 g of yeast extract to 1 L of water made ZY broth.
4.2.1.1.3 Preparation of 25% Aspartate Solution (w/v) Solution
Combining 25.0 g (0.188 mol) of aspartic acid and 8.0 g (0.20 mol) of NaOH in 
84 mL of water made a 25% aspartate solution.
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Figure 4.1. Summary of the PCR reactions used for chimeragenesis. The first reaction 
produces the megaprimer, which is used to finalize building a chimeric enzyme construct 
via megaprimer whole plasmid PCR (MegaWhoP PCR).
4.2.1.1.4 Preparation of 50X M Solution
A 1X M solution contains 50 mM PO4-3, 50 mM NH4Cl, and 5 mM Na2SO4. 
Combining 17.75 g of Na2HPO4, 17.0 g of KH2PO4, 13.4 g of NH4Cl, and 3.55 g of 
Na2SO4 in 80 mL of water produces a 100 mL portion of the 50X stock solution. The 
50X solution may form crystals over time that redissolve upon heating.
4.2.1.1.5 Preparation of 0.1 M FeCl3 in ~0.12 M HCl Solution
The FeCl3 in HCl solution was not autoclaved, as a large precipitate forms. A 1 
mL portion of concentrated HCl (approximately 12 M) and 2.7 g of FeCl3-6H2O was 
added to 99 mL of sterile water to produce the 0.1 M FeCl3 solution.
4.2.1.1.6 Preparation of the 1000X Trace Metal Solution
The following stock solutions of individual metals were prepared and autoclaved:
1 M CaCl2, 1 M MnCl2-4 H2O, 1 M ZnSO4-7H2O, 0.2 M CoCl2-6H2O, 0.1 M CuCh- 
2 H2O, 0.2 M NiCl2-6 H2O, 0.1 M Na2MoO4-2 H2O, 0.1 M Na2SeO3-5H2O, and 0.1 M 
H3BO3. To produce 100 mL of the 1000 X trace metal solution 50 mL of 0.1 M FeCl3 in 
~0.12 M HCl, 2 mL of 1 M CaCh, 1 mL of 1 M MnCh-4 H2O, 1 mL of 1 M ZnSO4- 
7H2O, 1 mL of 0.2 M CoCl2-6H2O, 2 mL of 0.1 M CuCh-2 H2O, 1 mL of 0.2 M NiCfc- 
6H2O, 2 mL of 0.1 M Na2MoO4-2 H2O, 2 mL of 0.1 M Na2SeO3-5H2O, 2 mL of 0.1 M 
H3BO3, and 36 mL of sterile water were combined. The final 1000X trace metal solution 
was not autoclaved.
4.2.1.1.7 Preparation of the 18 Amino Acid Solution
A solution containing 1 g of the following 17 amino acids (aa) in 90 mL of water 
was produced: sodium glutamate, aspartic acid, lysine, arginine, histidine, alanine, 
proline, glycine, threonine, serine, glutamine, asparagine, valine, leucine, isoleucine, 
phenylalanine, and tryptophan. The “17 aa” solution was then passed through a 0.2 um 
filter (not autoclaved) and stored at 4 °C.
The 18th amino acid is methionine and was stored separately as a 25 mg/mL 
solution. The working 18 amino acid solution (18 aa) was produced by mixing the two 
solutions in a 5:2::17 aa:methionine (v/v) ratio.
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4.2.1.2 Auto-Induction Medias
4.2.1.2.1 Preparation of MDG Media
MDG is a noninducing, minimal media. A 10 mL portion of MDG is produced by 
combining 20 ^L of 1 M MgSO4, 2 ^L of 1000X trace metals, 125 ^L of 40% glucose 
(w/v), 100 ^L of 25% aspartate (w/v), and 200 ^L of 50X M in 9.55 mL of water.
4.2.1.2.2 Preparation of MDAG-11 Agarose
MDAG-11 is a noninducing, minimal medium supplemented with amino acids.
To make 500 mL of agar, 5 g of agarose was added to approximately 475 mL of water, 
and then the solution was autoclaved. Upon removal from the autoclave, the solution was 
mixed well and allowed to cool on the bench top for approximately 10 min. Then 1 mL of 
1 M MgSO4, 100 ^L of 1000X trace metals, 1.25 mL of 40% glucose (w/v), 2 mL of 25% 
aspartate (w/v), 10 mL of 50 X M, 14 mL of 18 aa, and ampicillin to a final concentration 
of 100 ^g/mL was added. The solution was then mixed and the agarose plates poured.
4.2.1.2.3 Preparation of ZYM-5052 Media
ZYM-5052 is a complex auto-inducing medium. A 10 mL portion of ZYM-5052 
was made by adding 20 ^L of 1 M MgSO4, 2 ^L of 1000X trace metals, 200 ^L of 50X 
5052, and 200 ^L of 50X M to 9.57 mL of ZY broth.
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4.2.1.3 Chemical Transformation of Plasmid DNA into BL21 Star 
(DE3) Cells
A vial containing 50 ^L of BL21 Star (DE3) cells was thawed on ice. A 1 ^L 
portion of pET15b-gene was added to the cells and the sample gently mixed by tapping. 
The sample was then incubated on ice for 30 min. After incubation on ice, the sample 
was heat-shocked by placement in a water bath at 42 °C for 30 s, after which the cells 
were promptly removed and placed back on ice. A 250 ^L portion of SOC media was 
added to the sample, and then shaken at 225 rpm and 37 °C for 1 h. Afterwards, 20 and 
200 ^L portions were plated on LB+Amp agarose and the plates incubated overnight at 
37 °C.
4.2.1.4 Production of BL21 Star (DE3) Expression Cell Stocks
Plasmids with genes for the chimeric proteins inserted into pET15b were 
chemically transformed into BL21 Star (DE3) cells, plated on MDAG-11 plates 
containing 50 p,g/mL ampicillin, and incubated overnight at 37 °C. Two colonies were 
used to inoculate 2 mL of MDG media containing 50 p,g/mL ampicillin. The samples 
were shaken overnight at 225 rpm and 37 °C. Glycerol (100 ^L) was added to a 1 mL 
portion of each culture, the samples were lightly vortexed, and then stored at -80 °C until 
needed.
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4.2.1.5 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
(SDS-PAGE)
A 1-5 ^L portion of protein-containing sample and 5 ^L of 4X NuPAGE LDS 
Sample Buffer (Life Technologies) were combined and the total volume of the mixture 
brought to 20 ^L. The sample tube was incubated in boiling water for 10-15 min. After 
boiling, the sample was cooled at room temperature for 10-15 min. The protein sample 
was then loaded onto a NuPAGE Tris-Acetate Gel (Life Technologies) and the gel 
developed by applying 150 V in 3-(N-morpholino)propanesulfonic acid (MOPS) buffer 
(50 mM MOPS, 50 mM Tris base, 0.1% SDS, 1 mM EDTA, pH 7.7). The protein bands 
were visualized by staining with GelCode Blue Safe Protein Stain (Thermo Scientific), 
and the molecular weights of the protein bands were estimated by comparison with a 
PageRuler Plus Prestained Protein Ladder (Thermo Scientific, 10-250 kDa range).
4.2.2 Expression of Proteins
4.2.2.1 Introduction
Studier-based auto-induction was used for protein expression.3 The auto-induction 
procedure gave an approximately 10-fold increase in soluble sagebrush FPPase over 
induction with isopropyl P-D-thiogalactoside (IPTG). Expression was further enhanced 
using BL21 (DE3) Star cells (Life Technology), which have a truncation that deletes the 
C-terminal domain of the RNase E enzyme, preventing the degradation of mRNA.
4.2.2.2 Auto-induction of Expression
A sterile pipette tip was scraped across the top of a pET15b-gene-BL21 (DE3) 
Star frozen cell stock and used to inoculate 2 mL of MDG media, the inoculation culture 
was then developed by shaking at 225 rpm overnight at 37 °C. A 400 ^L portion (each) 
of the preculture was then used to inoculate two flasks containing 400 mL of ZYM-5052 
containing 50 ^g/mL of ampicillin. The samples were shaken at 300 rpm and 37 °C for 6 ­
8 h, and then allowed to cool to room temperature. Shaking continued for another 14-16 h 
(22-24 h total). Autoinduction of expression occurs as the culture’s cell growth reaches 
saturation. Sage FPPase and CPPase typically showed saturation of cell growth at an 
optical density at 600 nm (OD600) between 6 -8 . After shaking, the samples were cooled to 
4 °C, and the cells harvested by centrifugation at 4000 g and 4 °C. The 400 mL cultures 
were combined and centrifuged into a single cell pellet, and the supernatant poured off. 
The pellets were stored at -80 °C until needed.
4.2.3 Purification and Storage of Proteins 
Protein purification was performed at 4 °C. The cell pellets were removed from 
the freezer and thawed, followed by addition of 20 mL of lysis buffer (20 mM sodium 
phosphate at pH 7.4, 500 mM sodium chloride, 20 mM imidazole, 10 mM P- 
mercaptoethanol), Tween 20 to 0.1% (v/v), DNase I (5 p,g/mL), RNase A (10 p,g/mL), 2 
Roche Mini Complete protease inhibitor cocktail tablets (EDTA-free), and 20 mg of 
lysozyme. The cell pellet was fully suspended and the sample shaken at 120 rpm for 30 
min. The samples were then sonicated on ice 6  times for 10 s each (70% duty cycle and 
output control at 4), with a minimum 1-min cooling period between each sonication. The
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samples were then centrifuged at 10,000 g for 30 min, and the supernatant passed through 
a 0 .2  ^m filter.
HisTrap HP-5 columns (GE Life Science) were equilibrated with lysis buffer and 
the filtered supernatants were loaded onto the column via peristaltic pump at a flow rate 
of ~2 mL/min. The HisTrap column was then transferred to a GE Life Science AKTA 
FPLC system, where lysis buffer was passed through the column at a flow rate of 3 
mL/min until the ultraviolet (UV) absorbance at 280 nm stabilized, indicating the 
removal of unbound protein. Column-bound protein was eluted using a linear gradient of 
0 to 100% elution buffer (500 mM imidazole, 20 mM sodium phosphate buffer, pH 7.4, 
500 mM sodium chloride, 10 mM P-mercaptoethanol) over a period of 120 min. Five-mL 
fractions were collected during protein elution, and fractions containing protein (as 
indicated by UV absorbance at 280 nm) were analyzed by SDS-PAGE. The protein 
fractions containing highly pure protein (> 95%) were combined. In cases where protein 
purification levels were low, every other fraction in the expected range of elution was 
analyzed by SDS-PAGE, and the fractions containing chimeric protein were combined. 
The purified proteins were then precipitated by adding 470 mg of ammonium sulfate 
added to each mL of solution. The protein-ammonium sulfate solutions were allowed to 
stand overnight at 4 °C to facilitate precipitation.
The suspension of precipitated protein was centrifuged at 7000 g for 30 min, the 
supernatant removed, and the protein precipitate dissolved in a minimal amount of lysis 
buffer. The purified protein solution was then transferred to a Slide-A-Lyzer dialysis 
cassette (Pierce, 10K MWCO) and dialyzed twice against 20 mM Tris buffer, pH 8 , with 
500 mM sodium chloride, and then once against the same solution also containing 20%
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glycerol. Each dialysis was performed for a minimum of 4 h at a minimum ratio of 1:100 
(v/v) protein solution:buffer.
Flash frozen droplets of the protein solution were produced by filling a 50 mL 
plastic centrifuge tube with liquid nitrogen, immersing the tube in liquid nitrogen, and 
then slowly adding dialyzed protein solution drop by drop into the tube. After which the 
container was removed from the liquid nitrogen, loosely capped, and placed in the -80 °C 
freezer. Once the liquid nitrogen evaporated, the container cap was tightened and the 
pellets stored at -80 °C. This protocol conveniently produced approximately 100 ^L, 
frozen spherical samples of protein. Enzyme concentrations were determined using the 
BCA Protein Assay Kit (Pierce). All enzymes except those that did not express well (C9, 
F2-F7) were desalted with 0.1% formic acid via Amicon Ultra 0.5 mL centrifugal filters 
(EMD Millipore, 10K molecular weight cut-off (MWCO)) and submitted to the mass 
spectrometry facility for molecular weight verification by electrospray ionization mass 
spectrometry (ESI-MS) - many proteins precipitated upon desalting and could not be 
processed.
4.3 Synthesis of DMAPP, IPP, and GPP
Diphosphate substrates were synthesized from the corresponding alcohols 
according to the procedure of Davisson and coworkers and stored as solutions in 50 mM 
ammonium bicarbonate at -80 °C.4 Concentrations of the diphosphates were determined 
by a malachite green-based assay.5
4.4 Enzymatic Product Ratio Studies 
FPPase, CPPase, and chimeras of the two proteins were incubated with 
diphosphate substrates in 35 mM HEPES buffer, pH 7.6, containing 10 mM magnesium 
chloride, and 10 mM P-mercaptoethanol (reaction buffer), with only minor variations 
from the protocols described by Thulasiram and coworkers.6
4.4.1 Chain Elongation Products 
Enzymatic products formed under chain elongation conditions were obtained by 
combining 100-150 ^g of purified enzyme (or as much as possible in the cases of the F2- 
F7 chimeras due to poor soluble enzyme expression), 500 ^M IPP, 500 ^M DMAPP, and 
20 ^L of 10X reaction buffer in a total volume of 200 ^L. Each reaction was performed 
in triplicate. The samples were then incubated at 30 °C for 2 h. The diphosphate moieties 
were removed by the addition of 12 ^L of NEB Buffer 3 (1 M NaCl, 500 mM Tris-HCl, 
100 mM MgCl2, 10 mM dithiothreitol, pH 7.9) and 80 units of calf intestinal phosphatase 
(NEB), followed by incubation at 37 °C for 1 h. The samples were transferred to 100 X 
13 mm glass test tubes, and the reaction vessel washed with 600 ^L of water and then 
also added to the test tube. A 1 g portion of sodium chloride was added, and the sample 
was extracted 3 times with 800 ^L of methyl tert-butyl ether (MTBE). The MTBE extract 
was concentrated under a gentle stream of nitrogen until the volume was reduced to ~ 75 
^L. The extract was then transferred to a GC vial containing a 150 ^L glass insert 
(Agilent) and sealed with a crimp top.
The concentrated MTBE extract was analyzed by gas chromatography with flame 
ionization detection (GC-FID) analysis using the following protocol:
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- Agilent HP-5 capillary column (30 m X 0.320 mm, 0.25 micron)
- Ultra Inert Inlet Liner (Agilent, splitless, single taper with wool)
- He flow rate of 1 mL/min
- 5 ^L splitless injection by autosampler
- Inlet at 230 °C, detector at 250 °C
- Temperature program: 60 °C to 120 °C at 2 °C/min; 120 °C to 230 °C at 10 
°C/min; hold at 230 °C for 10 min.
Product ratios were determined using peak integration software (Agilent’s ChemStation), 
with an assumed signal response factor of one. The structures of the products were 
established by comparison of retention times and mass spectra with authentic samples.6
4.4.2 Irregular Products 
Products formed under irregular terpenoid coupling conditions were obtained by 
combining 100-150 ^g of purified enzyme (or as much as possible in the cases of the F2- 
F7 chimeras due to poor soluble enzyme expression), 3 mM DMAPP, and 20 ^L of 10X 
reaction buffer in a total volume of 200 ^L. Each enzyme was analyzed in triplicate. The 
sample was incubated at 30 °C for ~ 16 h, after which concentrated MTBE extracts were 
prepared for GC analysis as described above. The concentrated MTBE extracts were 
analyzed by GC-FID using the following protocol:
- Agilent HP-Chiral capillary column (30 m X 0.320 mm, 0.25 micron)
- Ultra Inert Inlet Liner (Agilent, splitless, single taper with wool)
- He flow rate of 1 mL/min
- 5 ^L splitless injection by autosampler
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- Inlet at 230 °C, detector at 250 °C
- Temperature program: hold at 50 °C for 3 min; 50 °C to 120 °C at 2 °C/min; 120 
°C to 230 °C at 10 °C/min; hold at 230 °C for 10 min
Product ratios were determined as described above, with the structures of products were 
determined by comparison of retention times and mass spectra with authentic samples.6
4.5 Determination of Apparent Michaelis-Menten Kinetic Parameters
4.5.1 Synthesis of [p-32P]DMAPP and |> 32P]IPP 
[P-32P] Labeled diphosphate substrates were prepared in two steps as described by 
Chen and coworkers.7 Dimethylallyl phosphate (DMAP) and isopentenyl phosphate (IP) 
were synthesized from their corresponding alcohols, and the [P-32P] labeled diphosphate 
substrates were prepared from their corresponding monophosphates. In a typical 
procedure, 65 nmol of monophosphate was incubated with 13 nmol of [y-32P]ATP (10 
Ci/mmol, Perkin Elmer), ~ 10 ng of Thermoplasma acididophilum (THA) isopentenyl 
phosphate kinase (IPK) in 100 ^L of IPK reaction buffer (100 mM HEPES buffer, pH 
7.5, 10 mM MgCl2, 10 mM P-mercaptoethanol, and 1 mg/mL bovine serum albumin 
(BSA)) at 30 °C overnight. The radiolabeled products were purified by cellulose column 
chromatography.8 Fractions were collected, and those containing substantial 
radioactivity, as determined with a Geiger counter, were combined in a round bottom 
flask. Solvent was removed to a volume of approximately 1 mL by rotary evaporation 
and the samples were stored at -20 °C until used.
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4.5.2 Kinetic Experiments 
Kinetic assays were performed in 35 mM HEPES buffer, pH 7.6, containing 10 
mM MgCl2, 10 mM P-mercaptoethanol, and 2 mg/mL of BSA in a total volume of 50 ^L 
at 30 °C. For chain elongation, unlabeled IPP was spiked with 1 ^L of [32P]IPP, and for 
formation of irregular terpenes, unlabeled DMAPP was spiked with 1 ^L of 
[32P]DMAPP. Samples were pre-incubated for 5 min at 30 °C before the reactions were 
initiated by the addition of enzyme. Typically, samples were incubated for 10 min, 
although it was necessary to increase the time to 20 min when turnover was slow. Assay 
mixtures were quenched with 125 ^L of a (100:13, v/v) solution methanol and 750 mM 
EDTA. A 20 ^L portion of the quenched sample was spotted onto a silica TLC plate, and 
the plates were developed with CHCl3/pyridine/formic acid/H2O (30:70:16:10, v/v/v/v). 
The TLC plates were imaged using a storage phosphor screen and scanning with a 
Typhoon 8600, with the radiological counts quantified using ImageQuant 5.2. Single 
point assays were measured in triplicate under initial velocity conditions where turnover 
of substrates was < 10%, with an upper limit of substrate concentrations at 6  mM.
4.5.2.1 Chain Elongation -  IPP and DMAPP
A series of experiments were performed to deduce the necessary boundary 
conditions for substrate and enzyme concentrations. Enzyme-free experimental controls 
did not show detectable background for formation of chain elongation products. 
Preliminary screens used 1X, 10X, 100X, and 1000X dilutions of purified enzyme and 74 
^M, 222 ^M, 667 ^M, 2000 ^M, and 6000 ^M concentrations of both DMAPP and IPP. 
The lowest combination [DMAPP] and [IPP] concentrations (the “optimal”
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concentrations) needed to give a maximal velocity was determined, and the [enzyme] 
required for ~ 1% turnover at these concentrations of IPP and DMAPP was estimated.
Then the initial rates were determined for varied [IPP] using the “optimal” 
[DMAPP] and [enzyme] determined above. The [IPP] concentration observed to 
maximize the initial rate became the “new optimum” [IPP]. A second set of assays was 
performed with varied [DMAPP] using an [enzyme] estimated to give 5% turnover based 
on the “new optimum” [IPP]. A “new optimum” [DMAPP] was determined, and the 
enzyme concentrations producing approximately 1% and 5% turnovers at maximized kcat 
calculated.
Apparent values for Michaelis-Menten constants for IPP and DMAPP were 
obtained by varying the concentrations of one substrate, while holding the concentration 
of the other substrate at the “new optimum” value. The [enzyme] giving ~1% turnover 
was used for the varying [IPP] experiment, whereas the [enzyme] giving ~5% turnover 
was used when varying [DMAPP].
4.5.2.2 Chain Elongation -  GPP
Apparent values of Michaelis-Menten constants for GPP were obtained as 
described above using the “new optimum” [IPP].
4.5.2.3 Irregular Terpenes -  DMAPP
Assays were typically conducted using 2 ^L of undiluted purified enzyme stock 
solutions and varied [DMAPP] between 74 ^M to 6000 ^M over 20 min at 30 °C. 
Enzyme-free experimental controls confirmed background formation of irregular
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terpenes, which were accounted for in the calculation of apparent Michaelis-Menten 
values.
4.6 Construction of Molecular Models
Molecular models of substrate-bound enzymes were built from an apo C3 
chimeric enzyme X-ray crystal structure (Brookhaven pdb 4KK2) and a DMASPP- and 
IPP-bound E. coli FPPase x-ray crystal structure (Brookhaven pdb 1RQI) .9 The software 
programs PyMol and UCSF Chimera were used to develop the models.10 First, all non­
active site water molecules were deleted from structure 1RQI. The residues G174 and 
E175 were missing from one monomer of structure 4KK2, and the missing residues were 
modeled into the crystal structure using UCSF Chimera’s Model/Refine Loops tool. 11 
The 1RQI structure was opened in UCSF Chimera and the refined 4KK2 structure 
overlaid on 1RQI. Structure 4KK2 is in the substrateless “open” conformation, whereas 
structure 1RQI is “closed.” The 4KK2 structure was taken to the closed conformation 
(4KK2_morph) by morphing the structure into 1RQI via the Morph Conformations tool. 
UCSF Chimera’s DockPrep tool can perform several tasks including deleting water 
molecules, repairing truncated side chains, adding hydrogens, assigning partial charges, 
and writing files in mol2 format. The tool is mainly utilized here to add hydrogens after 
adding or mutating residues, and to assign partial charges. At this point a DockPrep was 
performed on structure 4KK2_morph and a mol2 file saved (4KK2_morph_DockPrep) . 12
Structure 4KK2_morph_DockPrep was then overlapped with 1RQI in UCSF 
Chimera. The 1RQI sequence was opened, selected, and deleted, leaving DMASPP, IPP, 
and the active site waters behind in the 4KK2 structure. The Copy/Combine Molecular
Models tool was used to merge the two structural files into one (4KK2_overlap) and a 
DockPrep performed. Structure 4KK2_overlap was the parental structure from which all 
others models were built.
To build model structures of FPPase, CPPase, and select chimeric enzymes, 
amino acid mutations were performed on 4KK2_overlap using UCSF Chimera’s 
Rotamers tool. The highest-probability Dunbrack rotamer was selected for a mutation, 
except in the case of F231Y and D235N FPPase to CPPase mutations, where the 
rotomers best matching the amino acid conformations in structure 4KK2 were chosen.13 
A DockPrep was then performed on the model, followed by optimization of the energetic 
parameters of the models over 2 0 0 0  steps ( 1 0 0 0  steepest descent and 1 0 0 0  conjugate 
gradient) . 14
To build model structures with DMAPP in the electron donor site, IPP’s valency 
was cycled in Pymol, isomerizing the double bond and turning the substrate into DMAPP 
before performing the final DockPrep and energy minimization. In the production of 
models with the dimethyallyl carbocation (DMA+) and diphosphate in the electron 
acceptor site, the dimethyallyl (DMA)-diphosphate bond was removed in Pymol, and 
then bonds made between DMAPP in the electron donor site and DMA in the electron 
acceptor site to produce chrysanthemyl diphosphate (CPP) before performing the final 
DockPrep and energy minimization. The bonds formed to make CPP in the active site 
were then removed after energy minimization, and the appropriate valencies assigned, 
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The isoprenoid biosynthetic pathway is one of nature’s largest and most diverse. 
With over 62,000 natural products, terpenes include many well-known groups such as 
sterols, ubiquinones, carotenoids, and essential oils.1-3 Despite responsibility for a wide 
structural array of chemicals, isoprenoids are simply built by coupling 3-methyl-1-butyl 
(isoprene) units. Dimethylallyl diphosphate (DMAPP) and isopentenyl diphosphate (IPP) 
are the universal isoprene units coupled in one of four ways -  chain elongation, 
branching, cyclopropanation, and cyclobutanation -  to make the terpenoid skeletal 
backbones.2 Chain elongation is considered a regular or head-to-tail coupling, while the 
others are irregular or nonhead-to-tail.
The type I isoprenoid synthase (IS-1) fold is intimately involved in the isoprenoid 
biosynthetic pathway. The all a-helical IS-1 fold has been observed in multiple E- 
polyprenyl diphosphate synthases, enzymes catalyzing nonhead-to-tail reactions, and 
terpenoid cyclases, making enzymes exhibiting the structure members of a 
superfamily.2,4' 7 The prevalence of the IS-1 fold suggests divergent evolution from a 
common primordial ancestor early in the evolution of terpene biosynthesis. Five 
conserved regions of E-chain elongation enzymes exist and form the active sites of the
Genes for the closely related farnesyl and chrysanthemyl diphosphate synthases 
(FPPase and CPPase, respectively) were isolated from snowfield sagebrush Artemisia 
tridentata ssp. spiciformis, both enzymes being IS-1 fold homodimers.9 FPPase forms the 
regularly coupled, C15 compound farnesyl diphosphate with high efficiency and 
specificity, whereas CPPase is relatively inefficient and catalytically promiscuous 
exhibiting all the fundamental couplings in its products (geranyl diphosphate, chain 
elongation; chrysanthemyl diphosphate, cyclopropanation; lavandulyl diphosphate, 
branching; maconelliyl diphosphate, cyclobutanation). Despite an apparent catalytic gap 
between the enzymes, their sequence alignments show a striking 69% identity and 84% 
similarity, not only implying a recent divergence of the genes from a common origin, but 
also perhaps the evolution of cyclopropanation activity from an ancestral E-chain 
elongation enzyme.8 The staggering sequence and presumed structural resemblance, yet 
contrasting catalytic activities between the sagebrush enzymes yields a unique 
opportunity to probe structure-function aspects of the IS-1 fold.
The use of chimeric proteins has proven utility in the enzymologist’s toolbox.
In the case of FPPase and CPPase chimeragenesis, the tool is used to mimic evolution 
using DNA sequences that underwent the scrutiny of natural selection. Sagebrush FPPase 
and CPPase chimeras were built around the a-helices and loops of the IS-1 fold in an 
attempt to deduce the structural elements in the IS-1 fold responsible for catalytic 
selectivity and activity. Chimeras were assembled in both directions (turning FPPase into 
CPPase, and vice-versa) and done so using PCR in order to produce constructs that 
maintain wild-type enzymatic sequences. Product ratio and kinetic analyses were
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enzymes with few exceptions.8
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performed, if possible, in addition to molecular modeling of the parental enzymes and 
select chimeric enzyme constructs.
5.2 The N- to C-terminal Conversion of FPPase to CPPase
Four milestones along the N- to C-terminal transformation of FPPase to CPPase 
occur. First, approximately 19-, 5-, and 11-fold increases of KmDmapp,ea, Kmipp,eD, and 
KMGPP,EA, respectively, were observed at the C1 to C2 chimeric enzyme transition, 
associated with an N53V FPPase to CPPase mutation in the first conserved region of E- 
chain elongation enzymes (EA, binding to the electron acceptor site; ED, binding to the 
electron donor site; GPP, geranyl diphosphate). The second milestone is marked by chain 
elongation activity transitioning from preferential farnesyl diphosphate (C15) formation to 
geranyl diphosphate (C10) at chimera C10 due to an over 100-fold increase of KMGPP,EA. 
The loss of GPP binding ability observed with C10 appears to be the result of multiple 
mutations involving the helices that form the GPP binding pocket and a T171R FPPase to 
CPPase active-site mutation.
The third milestone appears at the C10 to C11 transition, where an approximately 
10-fold decrease in kcatDMAPP/IPP, a 17-fold increase in KmDmapp ea, and a 22-fold increase 
in Kmipp,eD occur, dropping the catalytic efficiency to CPPase-like levels. The drastic 
reduction in catalytic efficiency (kcat/KM) at the C10 to C11 chimeric enzyme transition is 
associated with a T194G active-site FPPase to CPPase mutation in the fourth E-chain 
elongase conserved region. The fourth and final milestone in the FPPase to CPPase 
metamorphosis transpires as significant irregular coupling ability appears at chimera C13, 
indicating a CPPase-like allowance of DMAPP binding to the electron donor site. The
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introduction of irregular coupling ability correlated with F231Y and D235N FPPase to 
CPPase mutations in the fifth conserved region. In contrast to CPPase, C13 preferentially 
formed the branched product lavandulyl diphosphate (LPP) over the cyclopropyl product 
chrysanthemyl diphosphate (CPP), indicating the C-terminal region outside the IS-1 fold 
is a significant determinant in the catalytic selectivity of the enzymes.
5.3 The N- to C-terminal Conversion of CPPase to FPPase 
Along the N- to C-terminal conversion of CPPase to FPPase, selective binding of 
IPP to the electron donor site, and thus catalytic propensity towards the chain elongation 
reaction, was regained at the F1 chimera, in addition to a recovery in GPP binding ability. 
Similarly to CPPase, the F1 chimera preferentially forms the cyclopropyl product CPP 
over the branched product LPP when condensing two DMAPP molecules. Significant 
irregular coupling ability was lost at chimera F2. In this, only chimeras containing 
complete IS-1 fold sequence from CPPase did not selectively bind IPP to the electron 
donor site, and therefore competitively catalyzed regular and irregular couplings when 
incubated with DMAPP and IPP. An FPPase-like catalytic efficiency was not restored at 
any point in the CPPase and FPPase transition, indicating the significance of the C- 
terminal region in defining catalytic activity.
5.4 The Significance of the C-terminal Region in Defining the Catalytic 
Selectivity and Activity of CPPase and FPPase 
Chimera C13 preferentially formed LPP when irregularly condensing two 
DMAPP molecules, whereas CPPase preferentially formed CPP. C13 differs from
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CPPase in that the C-terminal region contains sequence from FPPase. In addition, 
swapping the C-terminal region of FPPase with CPPase sequence (to produce chimera 
F13) reduced the catalytic efficiency over 8500-fold to CPPase-like levels. The C- 
terminal regions of FPPase and CPPase differ by two active site residues -  D256E and 
R343G. Although the mutations may not bear sole responsibility for the affect of the C- 
terminal region, D256E and R343G play substantial roles in the active site, and in turn, 
likely affect the catalytic activity and selectivity of the sagebrush enzymes.
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Figure A1. Representative GC-FID traces of regular and irregular coupling, alcohol 
products (post-calf intestinal phosphatase digestion). A. Ci0 products of CPPase under 
incubation with 500 p,M of DMAPP and IPP (C-OH, chrysanthemol, ~ 21.8 min; 
lavandulol, L-OH, ~ 22.2 min; iG-OH, 3-methylene geraniol, ~ 25.4 min; N-OH, nerol, 
~ 25 min; G-OH, geraniol, ~ 27.7 min; Agilent HP-5 column). B. C15 products of 
FPPase under incubation with 500 p,M DMAPP and IPP (Z,E-F-OH, Z,E-farnesol, ~
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Figure A2. Representative GC-FID traces of irregularly coupled products (post-calf 
intestinal phosphatase digestion). A, B. Irregular coupling products from incubation of 
CPPase and chimera C6 , respectively, with 3 mM of DMAPP (C-OH, chrysanthemol, 
—34.5 min; L-OH, lavandulol, —35.6 min; P-OH, planococcol, —36.7 min; M-OH, 
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Figure A3. Electron impact fragmentation of chrysanthemol. Fragmentation pattern
obtained from GC-MS analysis of irregular product formation by CPPase.
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Figure A4. Electron impact fragmentation of lavandulol. Fragmentation pattern
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Figure A5. Electron impact fragmentation of maconelliol. Fragmentation pattern
obtained from GC-MS analysis of irregular product formation by chimera C6.
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Figure A6. Electron impact fragmentation of nerol. Fragmentation pattern obtained
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Figure A7. Electron impact fragmentation of 3-methylene geraniol. Fragmentation
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Figure A8 . Electron impact fragmentation of farnesol. Fragmentation pattern obtained 
from GC-MS analysis of regular product formation of chimera C1.

















Figure A9. Electron impact fragmentation of Z.E-farnesol. Fragmentation pattern 
obtained from GC-MS analysis of regular product formation of chimera C1.
105
CPPase:
5'-CATAT GAC GAC GAC GC T GT C TAGTAAT C TGAACT C GCAAT T TAT GCAAGT C TAC GA 
AACCCTGAAATCTGAACTGATCCACGACCCGCTGTTTGAATTTGATGACGATAGTCGTC 
AGT GGGT GGAACGCAT GAT T GAC TATACCGTTCCGGGCGGTAAAATGGTCCGTGGCTAT 
AGTGTGGTT GAT T C C TAC CAAC T GC TGAAAGGTGAAGAACTGAC C GAAGAAGAAGCGT T 
TCTGGCGTGCGCCCTGGGCTGGTGTACGGAATGGTTTCAGGCTTTCATCCTGCTGCATG 
AC GATAT GAT GGAT GGCTCTCACACGCGTCGCGGT CAAC CGTGCTGGTTTCGTCTGCCG 
GAAGTTGGCGCAGTCGCTAT TAAC GAT GGTGTGCTGCTGC GTAAT CATGTTCACCGCAT 
C C T GAAAAAACAT T T C CAGGGTAAAGCGTATTACGTGCACCTGGTTGACCTGTT TAAC G 
AAACC GAAT T C CAGAC GAT T T CAGGCCAAATGAT T GATAC CATCTCGCGCCTGGCCGGT 
CAGAAAGAAC T GAGTAAATATAGCATGT C T C T GAAC CGTCGCATTGTTCAATATAAAGG 
CGCATATTACTCCTGCTACCTGCCGATCGCGTGTGCCCTGCTGATGTTTGGTGAAAATC 
T GGAC GAT TATGTCCAGGTGAAAGATAT T C T GGT C GAAC T GGGCAT GTAT TAC CAGAT C 
CAAAACGAC TAC C T GGATAC C T T T GGT GAC C CGAAT GT T T TC GGCAAAAC CGGTACGGA 
TAT T GAAGAATGCAAAT GTTCATGGCT GAT CGCAAAAGC T CT GGAAC T GGC CAAC GAAG 
AACAGAAGAAAAT T C T GT C GGAAAATTATGGCATCAAAGACC C GGC GAAAGTC GC CAAA 
GT GAAAGAAATTTACCATGCGCTGAAT C T GAAAGGT GC C TAT GAAGATTAC GAAACGAA 
C C T GTAT GAAAATAGCAT GAAAGCAAT CAAAGC TCACCCGTCTATTGCGGTGCAGGCAG 
T GC T GAAAT C T T GT C T GGAAAAAATGTATAAAGGT CATAAATAAGGAT C C-3'
Figure A10. DNA sequence of CPPase synthesized in E. coli context.
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FPPase:
5 ' - CATAT GAGCAGCAGCAAAAGCAT T GAC C T GAAAAGCAAAT T C C T GAAAGTT TAC GA 
CAC C C T GAAAAGC GAC C T GAT TAAC GAC CCGGCATTCGAATT T GAT GAC GATAGC C GT C 
AGTGGATTCAAAAAATGC T GGAC TATAAC GTTCCGGGCGGTAAACT GAAT CGCGGCCTG 
TCAGTGGTT GAT TCGTACCAGCTGCTGAAAGGCGGTGAACT GAGC GAC GAT GAAATT T T 
T C T GAGC T C T GCAC T GGGCTGGT GCAT C GAAT GGCT GCAGGC T TAT T T C C T GGT GC T GG 
AC GATAT TAT GGAT GAAT CTCATACCCGTCGCGGTCAACCGTGTTGGTTTCGTCTGCCG  
AAAGTC GGCAT GAT T GC GGC CAAC GAT GGTAT C C T GC T GC GTAAT CAT GT GC C GC GCAT 
CCTGAAAAAACACTTCCGCGGCAAACCGTATTACGTCGACCTGGTGGATCTGTTTAACG  
AAGTTGAAT TCCAGACCGCGAGTGGCCAAAT GATTGACCTGATCACCACCCTGGTGGGC  
GAAAAAGATC T GT C CAAATATAGT C T GT C CAT T CAT C GT C GCAT C GT T CAGTATAAAAC  
GGCCTATTACTCATTTTACCTGCCGGTCGCATGCGCTCTGCTGATGTTCGGTGAAGACC  
T GGATAAACAC GT T GAAGT CAAAAAT GT GC T GGT T GAAAT GGGCAC C TAT T T T CAGGTG 
CAAGAC GAT TAC C T GGAT TGCTTCGGTGCGCCGGAAGTTAT T GGCAAAAT CGGTACGGA 
CATC GAAGATT T TAAAT GT T CCTGGCTGGTCGT GAAAGCAC T GGAACT GGC TAAC GAAG 
AACAGAAGAAAAC C C T GCAT GAAAACTAC GGTAAAAAAGATCCGGCGTCAGTTGCCAAA  
GT CAAAGAAGTGTACCACACGCTGAAC CTGCAAGCGGTTTTCGAAGAT TAT GAAGCCAC 
C T C GTACAAAAAAC TGATTACGAGCATCGAAAATCACCCGTC TAAAGCGGTCCAAGCAG  
T T C T GAAAT CAT T C C T GGGTAAAAT C TACAAAC GC CAAAAATAAGGAT C C- 3 '





Figure A12. Hyperbolic plots for estimating the apparent Michaelis-Menten kinetic 
values of CPPase for the irregular coupling (varying DMAPP, blue) and chain 




Figure A13. Hyperbolic plots for estimating the apparent Michaelis-Menten kinetic
values of FPPase for the chain elongation reaction (varying GPP at 74 ^M IPP, green;





Figure A14. Hyperbolic plots for estimating the apparent Michaelis-Menten kinetic
values of chimera C6 for the chain elongation reaction (varying GPP at 25 ^M IPP,





Figure A15. Hyperbolic plots for estimating the apparent Michaelis-Menten kinetic
values of chimera F8 for the chain elongation reaction (varying DMAPP at 6 mM IPP,
blue; varying IPP at 6 mM DMAPP, brown).
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Table A1. Forward and reverse crossover primers used to form the megaprimers in the 
first step of the PCR chimeragenesis protocol. Reverse crossover primers are named as to 
reflect the chimeric enzyme they will produce, for example, the F_3_C primer was used 
to build the F3 chimera. (FP indicates forward primer).
PCR
P rim er Sequence (5 '-3 ')
C_1_F CCACTGACAGGCCGCGATTCAI 1 1 IACCGCCCGGAACGGTATAG
F_1_C GGAATCAACCACACTATAGCCACGGACCAGGCCGCGATTCAGTTTACCG
C_2_F GTCGCTCAGTTCACCGCCTTTCAGCAGTTGGTAGGAATCAACCACA
F_2_C CG CTTCTTCrTCGGTCAGTTCTTCACCTTTCAG CAG CTG GTACG AATCAACCA
C_3_F CAGTGCAGAGCTCAGAAAAATTTCATCGTCGGTCAGTTCTTCACCTTTCAGCAGTTG
F_3_C GCACGCCAGAAACGCTTCTTCTTCGCTCAGTTCACCGCCTTTCAGC




C_6_F CGACGTAATACGGTTTGCCGCGGAAATG T M M  T CAGGATGCGGTGAACATGATTAC
F_6_C GGTGCACGTAATACGCTTTACCCTGGAAGTGT M M  T CAGGATGCGCGG





F_9_C GAACAATGCGACGGTTCAGAGACATACTATATTTGGACAGATd T T T KGCCCACC
C_10_F CGGCAGGTAAAATGAGTAATAGGCCG T T T IATATTGAACAATGCGACGGTTCAGAGACATG
F_10_C CAGGTAGCAGGAGTAATATGCGCCTTTATACTGAACGATGCGACGATGAATGGAC
C_11_F GACTTCAACGTGTTTATCCAGGTCTTCACCAAACATCAGCAGGGCACACGC
F_11_C ACCTGGACATAATCGTCCAGATTTTCACCG AACATCAG CAGAGCG CATG C
C_12_F CCCATTTCAACCAGCACA! M M  GACTT CAACAT AAT CGTCCAG ATTTT CACCAAACAT CAGCAG
F_12_C CAGTTCGACCAGAATATCTTTCACCTGGACGTGTTTATCCAGGTCTTCACCGAACATCAG





Table A2. Representative electrospray ionization mass spectrometry (ESI-MS) analyses 
for molecular weight verification of the enzymes.















c F c 41751.7 41750.4
